Trading Analysis Report: MCD¶

Analysis date: 2026-10-14
Rating: Hold
Generated: 2026-10-14 20:29:56
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 238.31 Price As Of: 2026-10-14

MCD (McDonald's Corporation, NYQ) – Technical Report as of 2026-10-14¶

1. Summary¶

MCD is in a well-established primary downtrend. It is also showing the first signs of a tentative oversold bounce.

Downtrend: The close of 238.31 is about 28.8% below the 2026 closing high of 334.50 (2026-02-27). It is below a falling 50-day SMA (253.04) and a falling 200-day SMA (283.39), and the 50-day sits well under the 200-day.
Early repair: RSI has recovered from deeply oversold, MACD has crossed above its signal line, OBV has made a higher low, and price has held a 229–231 zone over several sessions.
Exhaustion signals: The weekly TD-9 count is +8 and the monthly z-score is -2.00. Both point to stretched selling.
Trend not repaired: Price is still below both major averages, MACD is below zero, and RSI is below 50. The data supports "oversold bounce inside a downtrend", not "trend reversal confirmed".

2. Indicators chosen and why¶

I chose 8 indicators that avoid overlap:

Trend: close_50_sma and close_200_sma, for medium- and long-term structure.
Momentum: macd (the verified snapshot also supplies macds and macdh) and rsi.
Volatility: atr, for stop distance and position sizing. The snapshot also supplies the Bollinger bands.
Volume: obv, to test whether volume confirms the bounce.
Exhaustion and stretch: td_9 and z_score, both multi-timeframe, for how extended the decline is.

I did not pull adx, supertrend or the DI lines. Trend strength is therefore inferred from the moving averages and price structure rather than measured directly.

Data integrity: The verified snapshot matches the individual indicator calls. The 50-day SMA is 253.04, the 200-day SMA is 283.39, RSI is 43.72, MACD is -4.97 and ATR is 4.24. I found no discrepancies.

3. Price structure (from the OHLCV data)¶

The decline came in steps:

Peak: The close high was 334.50 on 2026-02-27. The intraday high was 335.18 on 2026-03-02.
Mid-March to April: Price fell from about 322 (2026-03-17) to about 304 (2026-03-20), then to 286.22 on 2026-04-27.
May: A low close of 270.83 came on 2026-05-11.
Lower highs: Rallies peaked at 285.90 (2026-06-16) and 280.22 (2026-07-07), and each failed.
Lower lows: Closes of 262.67 (2026-06-25), 260.95 (2026-07-23) and 258.22 (2026-08-27) followed.
Breakdown: On 2026-09-23 price fell from 250.35 to 238.32, a loss of about 4.8% in one session. The intraday low was 234.03 and volume was 16.6M shares, the highest in the 252-row sample. The tools give no cause for this move.
Low: The intraday low was 229.20 on 2026-10-05. The lowest close was 230.88 on 2026-10-07.
Bounce: On 2026-10-08 price rose from 230.88 to 236.90 on 11.36M shares, the second-highest volume in the sample. Closes since then were 235.23, 235.65, 235.81 and 238.31.

Today's close of 238.31 was also the day's high (open 235.31, low 234.23). It essentially retraces to the 2026-09-23 post-gap close of 238.32. It is the highest close since 2026-09-22.

4. Trend: moving averages¶

50-day SMA (253.04): It has fallen steadily from 266.21 on 2026-09-14. Price is about 5.8% below it. It is the first major overhead reference and sits close to the 2026-09-22 session high of 252.06.
200-day SMA (283.39): It has fallen from 290.77 on 2026-09-14. Price is about 15.9% below it, so there is no long-term trend support nearby.
Bearish alignment: The 50-day is below the 200-day, and the gap widened from about 24.6 points on 2026-09-14 to about 30.4 now. The bearish structure is still deepening. The tool output doesn't date the cross, but the state has held since at least 2026-09-14.
Short-term: The 10-day EMA is 235.87 and price is above it. The Bollinger midline (20-day SMA) is 237.37 and price is just above it. Reclaiming these short-term averages is a modest positive.

5. Momentum¶

MACD (-4.97, signal -6.27, histogram +1.30): - The MACD line bottomed at -7.99 on 2026-10-02 and has risen every session since 2026-10-07. It is above its signal line, which is a bullish crossover. - It is still about 5 points below zero. The bearish regime is intact and only the rate of decline has eased. - The tool output doesn't date the crossover itself, so I can't say how fresh it is.

RSI (43.72): - RSI was below 30 for 11 consecutive readings, from 2026-09-23 (26.2) to 2026-10-07 (24.9). The low was 21.8 on 2026-09-30. - It jumped from 38.2 to 43.7 on today's +1.05% close. - Mild bullish divergence: The 2026-09-30 close was 230.94 with RSI 21.8. The 2026-10-07 close was 230.88 with RSI 24.9. That is a similar price low with a higher RSI low. - RSI is still below 50. In a downtrend, bounces often stall in the 50–60 region. That is a general heuristic, not something these tools validated.

6. Volatility¶

ATR (4.24): This is about 1.8% of price. It peaked at 5.12 on 2026-09-24 after the gap and has eased since. The window available only starts on 2026-09-14, so I can't compare it with a longer baseline.
Stop sizing: A 1.5×ATR stop is about 6.4 points (around 231.9). A 2×ATR stop is about 8.5 points (around 229.8). The 2×ATR level sits near the 229.20–229.61 lows from 2026-10-01 and 2026-10-05.
Bollinger bands: The lower band is 224.83, the mid is 237.37 and the upper is 249.90. Price is near the midline, so the daily z-score is neutral (+0.15). The lower band is about 5.7% below price and the upper band about 4.9% above. The upper band (249.90) is close to the pre-gap price area around 250.

7. Volume and OBV¶

OBV peaked at about +29.1M on 2026-08-24, the highest in the window pulled. It fell to a trough of -71.7M on 2026-09-30. That is sustained distribution through the decline.
Higher OBV low: The 2026-10-07 reading was -64.0M, above the 2026-09-30 trough, even though the closes were the same (230.94 and 230.88).
Same price, better balance: On 2026-09-23 the close was 238.32 with OBV at -52.1M. Today the close is 238.31 with OBV at -44.5M. At the same price, the volume balance is about 7.5M better.
OBV is still below its 2026-09-22 level of -35.5M, so the bounce hasn't yet undone the damage from the gap-down.
The big volume on 2026-10-08 came on an up day and the low held. That is consistent with buyers stepping in, but volume alone doesn't prove a bottom.
Recent daily volume of roughly 4.5–6.5M is well above the roughly 2–4M typical of late 2025. The stock is trading with heightened participation.

8. Exhaustion and stretch¶

TD-9 (weekly weighted highest): - Weekly: +8 (buy setup, 8 of 9). The weekly tier takes precedence. - Monthly: +7 (buy setup, 7 of 9). - Daily: -5 (sell setup, 5 of 9). This reflects the bounce and conflicts with the higher tiers.

My own reconstruction from the weekly and monthly closes suggests the weekly +8 and monthly +7 both include the current, unfinished bars. Treat this as inference, because the tool's bar convention isn't stated.

Weekly: A 9 would need the week ending 2026-10-23 to close below 236.50, the 2026-09-25 weekly close. A higher close would break the sequence.
Monthly: A 9 wouldn't complete before the December monthly bar.
Daily: A daily sell-setup 9 could complete around 2026-10-20 if closes keep exceeding the close four sessions earlier. That would give a short-term caution signal inside the larger bounce.

Z-score: - Weekly: -1.46. - Monthly: -2.00, right at the "statistically stretched" threshold. - Daily: +0.15.

The monthly and weekly readings show the decline is extended relative to recent history. In a persistent downtrend, a stretched reading can stay stretched, so it supports a mean-reversion watch rather than a signal on its own.

9. Confluence¶

Bullish or repair evidence: - RSI moved from 21.8 to 43.7 after 11 oversold readings, with a modestly higher RSI low. - MACD is above its signal line and has risen from -7.99. - OBV made a higher low and is better at the same price than on 2026-09-23. - The 229–231 zone was tested on 2026-09-30, 2026-10-01, 2026-10-05, 2026-10-07 and 2026-10-08 without a close below 230.88. - Weekly TD +8, monthly TD +7 and the monthly z-score of -2.00 all point to extended selling. - Price has reclaimed the 10-day EMA and the Bollinger midline.

Bearish or caution evidence: - Price is below falling 50- and 200-day SMAs, with a 50-below-200 configuration that is still widening. - The pattern of lower highs and lower lows has run from March through October. - MACD is below zero, and RSI is below 50. - OBV is still far below its August level and below its 2026-09-22 level. - The bounce is only about 3.2% off the 230.88 closing low. - A daily sell-setup count is building and could exhaust the bounce near term. - Each earlier bounce failed (2026-07-02, 2026-06-16).

10. Levels and scenarios¶

These are reference levels taken from price data. I have not validated any of them as support or resistance beyond the dated touches noted.

Reference levels: - Below price: 234.23 (today's low), 230.88 (2026-10-07 close), 229.20 (2026-10-05 intraday low). - Above price: 242.56 (2026-09-24 high), about 250 (2026-09-22 close of 250.35 and the Bollinger upper at 249.90), then 253.04 (50-day SMA, falling).

Scenarios: - Relief extension: A hold above about 230–231 and a close above 242.56 would open the path toward the 250–253 area. Stronger confirmation would be RSI above 50, MACD moving toward zero, and OBV rising above -35M. - Failure and retest: A close below 230.88, and especially below 229.20, would put price at the lowest levels in the 252-session sample and invalidate the base. The weekly TD count would then likely complete a 9, which is a reversal watch but not a guarantee. - Choppy consolidation: The 229–231 floor and the 242–250 ceiling could hold price in a range while the 50-day SMA drifts down toward price. That is plausible given ATR near 4.2.

11. Cautions¶

No news, earnings or fundamental data were available to me. I can't explain the 2026-09-23 gap or the 2026-10-08 volume spike.
The TD-9 and z-score outputs are computed from OHLCV rather than a standard library. Weekly and monthly counts include unfinished bars and can change before the bars close.
MCD paid $1.86 per share on four ex-dates (2025-12-01, 2026-03-03, 2026-06-02, 2026-09-01). That annualizes to $7.44, about 3.1% of the current price. The pattern suggests the next ex-date falls around early December, but that is inferred and not confirmed.
This report covers technical evidence only. The trading decision is left to the next stage.

12. Key points¶

Category	Indicator	Latest reading	Interpretation
Price	Close (2026-10-14)	238.31 (high 238.31, low 234.23, volume 5.19M)	Closed at the day's high; highest close since 2026-09-22
Drawdown	Close vs 2026-02-27 high	334.50 → 238.31 (about -28.8%)	Deep, persistent downtrend
Trend	50-day SMA	253.04 (falling)	Price about 5.8% below; first overhead reference
Trend	200-day SMA	283.39 (falling)	Price about 15.9% below; 50-day under 200-day, gap widening
Short-term trend	10-day EMA / Bollinger mid	235.87 / 237.37	Price just above both; early positive
Momentum	MACD / signal / histogram	-4.97 / -6.27 / +1.30	Above signal but below zero; momentum improving in a bearish regime
Momentum	RSI	43.72 (low 21.78 on 2026-09-30)	Recovered from oversold; below 50; mild bullish divergence
Volatility	ATR	4.24 (peak 5.12 on 2026-09-24)	About 1.8% of price; 2×ATR ≈ 8.5 points
Volatility	Bollinger lower / upper	224.83 / 249.90	Upper band sits near the pre-gap 250 area
Volume	OBV	-44.5M (trough -71.7M on 2026-09-30)	Higher low; better than 2026-09-23 at the same price; still below 2026-09-22 level
Exhaustion	TD-9 weekly / monthly / daily	+8 / +7 / -5	Higher tiers show buy-setup exhaustion; daily sell setup building
Stretch	Z-score weekly / monthly / daily	-1.46 / -2.00 / +0.15	Monthly stretched to the threshold; daily neutral
Key levels	Lows tested	229.20 (2026-10-05), 230.88 (2026-10-07 close)	Tested on several dates; a close below breaks the base
Key levels	Overhead	242.56, about 250, 253.04	Staged resistance before the 50-day SMA
Overall technical bias	Technical evidence	Primary downtrend, oversold bounce in progress	Not a confirmed reversal; confirmation would be a close above 242.56 and then 250

Sentiment Analyst¶

Overall Sentiment: Mildly Bullish (Score: 5.7/10) Confidence: Low

Scope and data limits. Window is 2026-10-07 to 2026-10-14 for MCD (McDonald's Corporation, NYQ). Reddit was skipped (disabled by config), so there is no signal from it. The news feed is 20 headlines only, with no article bodies, no dates per item and no sentiment scores. All 25 StockTwits messages fall in a single session on 2026-10-14 (about 18:17Z to 23:31Z), so they show one day's mood, not a week-long trend. Only 9 of the 25 messages carry a user label. Confidence is therefore low.

1. Source-by-source breakdown

News (Yahoo Finance, 20 headlines). About 9 are MCD-specific, about 8 are peer or sector items, and 3 are generic. I cannot tell whether MCD appears in the generic dividend-raise and 'safe-and-steady' lists, so I do not count them. - Constructive MCD items: Zacks 'McDonald's (MCD) Increases Despite Market Slip' (relative strength); 'Can MCD's Marketing Reset Help Improve Customer Engagement and Sales?'; TheStreet 'McDonald's plans major store changes to attract more customers'; and the Simply Wall St 'Restaurant NEXT push' piece. - Cautionary MCD items: Zacks 'McDonald's Stock Down 23% in 6 Months: Should Investors Buy the Dip?' sets a weak price backdrop but uses dip-buying framing. Insider Monkey 'Trades at 18 Times Earnings. Is the $8.5B Fix Priced In?' asks whether the turnaround is already reflected in the price. The bodies are not provided, so I cannot say what the '$8.5B fix' consists of. - Valuation framing is roughly neutral. Simply Wall St says MCD 'could be 1% overvalued', which is close to fair value on that model. - Comparison pieces (Darden vs. McDonald's for income investors; SBUX vs. MCD vs. YUM) are neutral, income and defensive in tone. - Peer and sector items skew negative: 'Wendy's store closures may be just the beginning, analyst warns'; Zacks 'Bear of the Day: Krispy Kreme'; 'Whataburger closes its high-tech restaurants'; and Chipotle -4% on Oct 12 after Starbucks denied a takeover bid. Whether weak peers help or hurt MCD (share gain vs. weak category demand) is not addressed in the headlines. CAKE +17% in a month is a positive outlier. - Net news read: neutral to slightly cautious on the stock's trend, constructive on the turnaround and marketing narrative, and mixed on the sector.

StockTwits (25 messages). - Labeled: 8 Bullish (32%), 1 Bearish (4%), 16 unlabeled (64%). Among the 9 labeled messages the split is about 89/11 bullish, close to the 90/10 level that can signal over-extension. With n=9, that ratio is fragile. The 8 bullish posts come from 7 unique authors, because @mclovinstocks posted twice ('Just bought more' and 'Buy as much as you can guys and girls'). Several bullish posts are one-liners ('I'm lovin it', a bare $MCD, a joke about fries) with no thesis. - Unlabeled: by my own subjective reading, about 10 lean constructive, about 2 lean skeptical or frustrated, and about 4 are neutral noise. - Constructive: 'safe haven during turbulence'; 'boring but recession proof'; 'on track to have 2 consecutive green weeks which hasn't been done since early June'; 'Bottom is in'; and a macro comment that if $TNX (10-year yield) has peaked, MCD finding buyers 'makes total sense'. @justanaveragekid posted three taunts at put holders ('how is going with your puts bro?', 'another screwed putholder'), which implies bears were active and were hurt on the day's up move. - Skeptical or frustrated: @SouthWaterTribe ('will give it allll up tomorrow') and @mikeol ('can this thing just have a F'n 2% day'). - Noise: a WSJ Zuckerberg joke, an unverified BYND/MCD Germany partnership comment, a blank post, and a Taco Bell remark. - Bearish evidence is a single valuation-based post (@Kumbaya171: 'should be 125 not over 200'), a long-horizon fundamental call with no catalyst. - Technical chatter: @rosilaros 'Watch for $240 break tomorrow' implies $240 is treated as resistance. A $247.50 call expiring 10/16 priced at $0.09 suggests the stock sits below that strike. Both price levels are inferred from user comments only, and I have no verified price data.

Reddit. No data (skipped by config). I cannot say anything about r/wallstreetbets, r/stocks or r/investing.

2. Cross-source divergences and alignments - Divergence: retail is clearly more bullish than the news flow. StockTwits is dominated by 'bottom is in' and 'buy more' posts, while the headlines frame MCD as a stock that has fallen about 23% over six months and is still being asked to prove its turnaround. Retail may be leaning into a bounce that institutional-style coverage has not yet confirmed. Alternatively, one up day may be driving the bullish tone. - Alignment: both sources treat MCD as a defensive, income and 'safe haven' name (Darden vs. MCD income comparison; 'recession proof'; 'safe haven during turbulence'). Both also acknowledge a weak recent trend, via the six-month drawdown headline and the 'yearly lows' and 'first two green weeks since early June' comments. - Valuation is the main sticking point. The news is roughly neutral (about fair value on one model), and the only bearish retail voice argues the stock is far too high. The bulls offer little valuation support.

3. Dominant narrative themes 1. Defensive rotation. Money rotating from tech into staples and quality names at yearly lows, with a falling-yields tailwind if $TNX has peaked (one user's view, unverified). 2. Dip-buying and bottoming. 'Buy the dip' framing in the news and 'bottom is in' on StockTwits, after a prolonged decline. 3. Turnaround and marketing reset. Restaurant NEXT, store changes, the marketing reset and the $8.5B fix, with debate over whether this is priced in. 4. Weak restaurant peers. Wendy's closures, Krispy Kreme, Whataburger and Chipotle volatility. 5. Squeezed put holders. Mocking of bears is a short-term sentiment-extension marker, not a fundamental signal.

4. Catalysts and risks surfaced by the data - Catalysts: continued relative strength and a sustained break above the $240 area (retail-cited, unverified); rotation into defensives and any further easing in yields; evidence that the marketing reset and store changes lift traffic; and the dividend and income-investor appeal. The evidence includes no earnings date, so the trader should check the reporting calendar separately. - Risks: the 'give it all up tomorrow' fade risk after a single strong session; the six-month drawdown showing the trend has not clearly reversed; unclear payoff from the $8.5B investment (headline only); sector-wide weakness (Wendy's closures, Krispy Kreme); a rotation back into tech that drains defensive flows; valuation pushback ('should be 125'); and retail crowding if bullish labeling climbs further from an already one-sided base. - Past sentiment is not predictive; treat this as one input alongside fundamentals and technicals.

5. Summary table

Signal	Direction	Source	Supporting evidence
Labeled retail ratio	Bullish (thin sample)	StockTwits	8 Bullish vs 1 Bearish of 25 messages (about 89% of the 9 labeled); 7 unique bullish authors; near over-extension threshold
Unlabeled retail tone	Mildly Bullish	StockTwits	About 10 of 16 constructive ('safe haven', 'recession proof', 'bottom is in'); about 2 skeptical; about 4 noise (subjective read)
Put-holder taunting	Bullish short-term, contrarian caution	StockTwits	Three @justanaveragekid posts mocking puts; 'will give it all up tomorrow' pushback
Valuation bear case	Bearish	StockTwits	@Kumbaya171: 'should be 125 not over 200' (single post, no catalyst)
Technical levels	Neutral to Bullish	StockTwits	'$240 break' watch; $247.50 10/16 call at $0.09 (speculative, inferred levels)
Defensive rotation / yields	Bullish	StockTwits	$TNX 'peaked' comment; staples at 'yearly lows' vs. tech; 'two consecutive green weeks'
Price trend backdrop	Bearish	News	Zacks: 'Down 23% in 6 Months: Should Investors Buy the Dip?'
Relative strength	Mildly Bullish	News	Zacks: 'Increases Despite Market Slip'
Turnaround / strategy	Neutral to Mildly Bullish	News	Restaurant NEXT, marketing reset, store changes; '$8.5B fix priced in?' (bodies not provided)
Valuation	Neutral	News	'Trades at 18 Times Earnings'; Simply Wall St 'could be 1% overvalued'
Peer and sector read-through	Mildly Bearish	News	Wendy's closures, Krispy Kreme 'Bear of the Day', Whataburger closing, Chipotle -4% on Oct 12
Reddit	n/a	Reddit	Skipped by config; no signal

News Analyst¶

MCD (McDonald's Corporation): News and Macro Report, week ending 2026-10-14¶

1. Bottom line¶

The macro backdrop is hostile to MCD. The 10-year Treasury yield is about 5.2%, near its highest since 2002. Inflation re-accelerated, with September CPI up about 0.65% month over month. Prediction markets price more Fed hikes, not cuts. MCD is a defensive, dividend-oriented, long-duration-style equity, so rising yields compete directly with it.
Company news is mostly sentiment and narrative, with no hard catalyst. MCD is reported to be down about 23% over six months. Coverage centers on a marketing reset, a "Restaurant NEXT" store-format push, and an "$8.5B fix." Peers are under stress: Wendy's closures, Whataburger pulling back tech, and Chipotle down 4% on Oct 12.
Two things could move the stock. One is the Fed meeting in late October. The other is MCD's Q3 earnings, whose date I could not confirm from the tools.

2. MCD-specific news¶

Limitation: the news tool returned headlines and links only, with no article text. The points below come from headlines. I could not verify figures, quotes, or details.

Theme	Headline evidence	Read-through
Stock performance	"McDonald's Stock Down 23% in 6 Months: Should Investors Buy the Dip?" (Zacks). "MCD Increases Despite Market Slip" (Zacks).	The stock has been weak over six months but showed relative resilience on at least one down-market day.
Valuation	"MCD Trades at 18 Times Earnings. Is the $8.5B Fix Priced In?" (Insider Monkey). "Could Be 1% Overvalued After Its Restaurant NEXT Push" (Simply Wall St.).	Around 18x earnings is modest against MCD's historical premium multiple. The "$8.5B" likely refers to a reinvestment or remodel program, but I can't confirm that. Simply Wall St. calls it roughly fairly valued.
Strategy	"Plans major store changes to attract more customers" (TheStreet). "Can MCD's Marketing Reset Help Improve Customer Engagement and Sales?" (Zacks).	Management is in a traffic-recovery and reinvestment phase. That likely means near-term spending and uncertain payback.
Income appeal	"Darden vs. McDonald's: Better Buy for Income Investors" (24/7 Wall St.). "3 Stocks Just Declared Dividend Raises" (Motley Fool).	The dividend is the main bull argument. A roughly 5.2% risk-free yield erodes that argument.
Peer stress	"Wendy's store closures may be just the beginning, analyst warns." "Whataburger closes its high-tech restaurants." "Krispy Kreme: Bear of the Day."	Quick-service restaurant (QSR) demand and unit economics look weak, especially for weaker players. This can help MCD through share gains and scale, but it also signals a soft category.
M&A and sector	"Chipotle Falls 4% as Starbucks Denies Takeover Bid" (Oct 12).	There is sector-level headline volatility. The details are unclear and don't directly involve MCD.
Comparisons	Starbucks vs. MCD vs. YUM (Insider Monkey). Chipotle European expansion (Zacks).	Investors are weighing MCD against growth-oriented peers.

Not available from the tools: the Q3 earnings date, analyst price-target changes, MCD price and volume data, and options positioning. In recent years MCD has reported in late October or early November. Please confirm the date before trading around it.

3. Macro picture (FRED data)¶

Indicator	Latest	Trend and notes
10-yr Treasury yield	5.21% (Oct 13)	Up from 4.03% a year ago. It was 4.72% in mid-August and peaked at 5.31% on Oct 5. Headlines say the highest since 2002.
10s–2s spread	+0.37% (Oct 14)	Down from +0.51% on Oct 7. The curve is flattening, which fits a front end that prices hikes. The 2-year yield is roughly 4.8%. This is my arithmetic from the two series.
Fed funds (effective)	3.75% (Sept avg)	Flat at 3.63–3.64% from January to August, then up in September. The step up suggests a hike around the September meeting, but I could not confirm that from the data.
CPI (all items, index)	336.298 (Sept)	+0.65% m/m in September, +0.40% in August, and +0.07% in July. It is up 3.46% over ten months. A headline cites 3.7% year over year, which I couldn't check against FRED.
Core PCE (index)	130.455 (Aug)	+0.25% m/m in August and +2.59% over ten months, about 3.1% annualized. Core inflation is firm and above target.
Unemployment	4.2% (Sept)	Down from 4.5% in November 2025, with a low of 4.1% in July–August. The labor market is stable.
Real GDP	$24.41T (Q2)	About +0.55% q/q in Q2 and +0.62% in Q1, roughly 2.2–2.5% annualized. Growth is moderate.
VIX	15.27 (Oct 13)	Calm and in a 14–18 range for two months. Equity markets look complacent given the rate shock.

4. Global and market news (past 7 days)¶

Rates shock: "10-year yield rises following hot inflation data." "Bond yields are surging worldwide, and France is on the 'ugly side.'" "Rapid bond yield moves have preceded nearly every major financial blowup." "Bubble-like valuations and debt crisis chatter."
Rate-hike expectations: Bloomberg reported "Hot Inflation Lifts October Rate-Hike Bets." Gold and Bitcoin fell, and Bitcoin dropped below $83K.
Strategists and investors: BlackRock turned more bearish on stocks. A BofA fund-manager survey says managers won't dump stocks for bonds until yields reach about 5.9%. That implies the market still sees room for yields to climb.
Housing and consumer credit: Mortgage rates are at a nearly three-year high, with 8% discussed. This hits discretionary budgets, especially for lower- and middle-income households who are a core MCD customer base.
Energy and geopolitics: Oil fell to about $103 after Trump said the US won't attack Iran before the midterms. Oil is still very elevated, which acts as a gasoline tax on consumers. The midterm elections are Nov 3.
Equities: Tech was volatile, with AI-trade jitters and chip weakness. Banks rose on JPMorgan and Goldman earnings. The Nasdaq dropped 1.65% in one session, and small caps were deeply oversold (Russell 2000 RSI about 28). Earnings season has started.

5. Prediction markets (Polymarket)¶

Event	Probability	Volume	Comment
No Fed cuts in 2026	97%	$8.9M	Cuts are effectively priced out.
"Another" Fed hike in 2026	82% (+4pp w/w)	$0.78M	"Another" implies a hike has already occurred.
Exactly 2 hikes in 2026	65%	$0.18M	This is thin, and it is unclear whether it counts hikes already delivered.
Exactly 1 hike / exactly 3 hikes	18% / 18%	thin	Exactly 3 hikes rose 7.5pp this week.
US recession by end of 2026	8% (+1pp)	$2.3M	The crowd sees a growth scare as unlikely.
Crude oil new all-time high by Dec 31	12%	$1.9M	Tail risk.
Iran charges Hormuz fees by Dec 31	18%	$0.3M	Geopolitical tail risk.
Military action against the Saudi East-West pipeline by Oct 31	38%	$0.05M	Very thin, so treat it cautiously.

Takeaway: the market expects a stagflation-lite scenario. Rates stay high or go higher, recession risk is low, and oil is a risk. Several of these contracts have low volume, so weigh them accordingly.

6. Implications for MCD¶

Headwinds 1. Rate competition for yield. With the 10-year at 5.2% and rising, the relative appeal of MCD's dividend yield falls. MCD historically behaves like a bond proxy and is vulnerable to further yield spikes. The BofA survey suggests the market tolerates yields up to roughly 5.9%. 2. Financing costs. MCD runs a leveraged balance sheet and relies on franchise-rent and royalty cash flows. A higher discount rate pressures valuation. Refinancing costs rise as well. 3. Consumer squeeze. CPI is running hot, oil is above $100, and mortgage rates are near 8%. Lower-income consumers may cut restaurant visits. The weak peer news (Wendy's, Krispy Kreme) fits this. 4. Reinvestment drag. The store-format overhaul and marketing reset likely weigh on near-term margins and free cash flow.

Tailwinds and mitigants 1. Value positioning. In a squeezed consumer environment, MCD's value menu and scale can drive trade-down and share gains from weaker QSR rivals. 2. Low recession odds. Unemployment is 4.2% and recession odds are 8%, so a sharp traffic collapse is not the base case. 3. Valuation. About 18x earnings after a roughly 23% drawdown gives a more modest starting point than in prior years. 4. Defensive rotation. If the AI and tech trade or the bond market wobbles further, defensives could attract flows. Higher yields work against this, though. 5. Relative strength. At least one Zacks headline notes MCD rising on a down-market day.

7. Key dates and catalysts to watch¶

FOMC, late October. My recollection of the calendar is Oct 27–28. Please verify. A hike is being debated, and the outcome and guidance are the biggest macro swing factor.
MCD Q3 earnings. Date unconfirmed. Watch US same-store sales and traffic, low-income consumer commentary, the Restaurant NEXT spending plan, and margins.
Nov 3. US midterm elections.
Mid-November. October CPI release. Another hot print would extend the yield rally.
Geopolitics. Iran, Hormuz and Saudi pipeline headlines move oil, which feeds into consumers and inflation.
10-year yield levels. Watch 5.31% (the recent high) as a breakout level. A move toward the 5.9% BofA threshold would be a stress scenario.

8. Summary table¶

Category	Key point	Data or evidence	Implication for MCD
Company sentiment	Stock down about 23% over six months. About 18x earnings.	Zacks, Insider Monkey (headlines only)	Valuation is more modest, but momentum is negative.
Company strategy	Marketing reset, Restaurant NEXT and store changes, "$8.5B fix"	TheStreet, Zacks, Simply Wall St. (headlines only)	Reinvestment phase. Payback is uncertain, and there is a near-term margin and FCF drag.
Peers and sector	Wendy's closures, Whataburger rollback, Krispy Kreme bearish, Chipotle −4%	Yahoo, TheStreet, Zacks, Motley Fool	The category is soft. Scale and value may help MCD, but sentiment is weak.
Rates	10-year at 5.21%, near the highest since 2002. Peak 5.31% on Oct 5.	FRED DGS10	Strong headwind for bond-proxy and dividend stocks.
Yield curve	10s–2s at +0.37%, down from +0.51% a week ago	FRED T10Y2Y	The front end is pricing in hikes.
Fed	Funds rate 3.75% (Sept), up from 3.63%. No cuts in 2026 at 97%. "Another" hike at 82%.	FRED, Polymarket	Tightening bias. The late-October FOMC is a key risk.
Inflation	CPI +0.65% m/m in September, about 3.7% y/y per a headline. Core PCE +0.25% m/m in August.	FRED CPIAUCSL, PCEPILFE	Input costs and consumer pressure. Hikes are more likely.
Labor and growth	Unemployment 4.2%. Real GDP about 2.2–2.5% annualized.	FRED UNRATE, GDPC1	The consumer is supported by jobs. Recession is not the base case.
Recession odds	US recession by end of 2026 at 8%	Polymarket	Low odds limit the downside from a traffic collapse.
Energy and geopolitics	Oil about $103. Iran and Hormuz risk. 12% chance of a crude all-time high.	News, Polymarket	A gasoline tax on low-income customers. Tail risk.
Consumer credit	Mortgage rates near 8% and at a three-year high	Yahoo Personal Finance	Discretionary budgets are squeezed.
Market sentiment	VIX 15.27. BlackRock more bearish. Bubble and debt-crisis chatter.	FRED VIXCLS, Yahoo	Complacent volatility against a rate shock. Gap risk if yields spike.
Data gaps	No MCD price data, earnings date, analyst targets, or article text	n/a	Confirm the Q3 earnings date and price action before trading.

Overall read: the macro setup is net negative for MCD in the near term because of rates, inflation and a squeezed consumer. The company's value positioning, lower valuation and low recession odds partly offset that. The late-October FOMC and the MCD Q3 report are the main events. Please confirm the earnings date and current price levels before the final decision.

Fundamentals Analyst¶

MCD (McDonald's Corporation) – Fundamental Report¶

As of 2026-10-14 | NYQ | Consumer Cyclical / Restaurants

1. Bottom line¶

Earnings are growing at a steady mid-single-digit rate, but the stock has de-rated sharply. Q2'26 diluted EPS was $3.32, up about 5.7% YoY. Net income was up 4.8% and revenue up 3.7%. The implied share price is about $238, roughly 30% below the 52-week high of $341.75, and about 4% above the 52-week low of $229.20.
The P/E is now about 19.4x, down from roughly 27x in February 2026. That comparison uses a ~$333 price and about $12 of EPS, so it is approximate. The decline comes from multiple compression, not an earnings collapse.
Margins and cash conversion are excellent. Operating margin is about 46–47% and operating cash flow runs about 1.2x net income.
Insiders are not buying. Across 90 Form 4 records (Oct 2024 to Aug 2026) there is not one open-market purchase. Selling has faded since the February 2026 peak.
My tools can't explain the de-rating. They have no comparable-sales, traffic, guidance, or news data, and no debt breakdown. Those are the main gaps for the next analyst.

2. Data scope and caveats¶

Latest filed period is Q2 2026 (quarter ended 2026-06-30). The tools show no new filings in the past week, so there are no week-specific fundamental events. The most recent insider record is dated 2026-08-07.
Q4 is missing from the quarterly income and cash-flow tables. Q4 figures come from the 10-K. I derived the Q4'25 figures below from TTM totals and flagged them as derived.
Several fields are unreliable:
Total liabilities and gross profit are "unavailable" in the statements.
Cost of Revenue (about $680M a quarter) doesn't reconcile with the vendor's $15.9B gross profit, so I ignored it.
Total debt and net debt aren't provided. EV/EBITDA and interest coverage can't be calculated from this data.
The vendor's TTM free cash flow of $6.26B is questionable. The three visible quarters alone (Q3'25, Q1'26, Q2'26) sum to about $6.12B of FCF. That would imply a near-zero Q4'25, which looks wrong. Either the basis or the period differs, and true TTM FCF is probably higher.
The share price isn't quoted directly. I inferred about $238.3 from P/E × EPS (19.359 × 12.31) and from forward P/E × forward EPS. Both give the same figure.

3. Valuation and market snapshot¶

Metric	Value	Comment
Market cap	$168.6B
Implied price	about $238	Derived
P/E (TTM) / Forward P/E	19.36x / 17.31x	Forward EPS $13.77 is about 12% above TTM EPS of $12.31
PEG	2.49	Implies the market is pricing about 8% EPS growth. Not cheap on a growth-adjusted basis
Price/Book	-164.8x	Not meaningful (negative equity)
Dividend yield	3.27%	Implies about $7.8 a share annualized (derived)
Beta	0.447	Defensive
52-week range	$229.20 – $341.75	Price is about 4% above the low and about 30% below the high
50-day / 200-day average	$253.76 / $286.61	Price is about 6% below the 50-day and about 17% below the 200-day average
EPS (TTM)	$12.31
Profit margin / Operating margin	31.7% / 46.5%
ROA	13.25%
Current ratio	1.08

Forward EPS looks demanding. The forward estimate implies about 12% growth, against reported EPS growth of 5–7% over the last three quarters. Forward EPS may also be on an adjusted basis, while TTM EPS is GAAP. Either the growth has to accelerate or estimates are at risk of being cut.
The price is below both moving averages. The trend is negative until the stock reclaims the 50-day average of about $254. The $229 area is the nearest reference level.

4. Income statement trends (USD millions, except EPS)¶

Quarter	Revenue	YoY	Op. income	Op. margin	Net income	Diluted EPS
Q1'25	5,956	-3.5%	2,648	44.5%	1,868	2.60
Q2'25	6,843	+5.4%	3,232	47.2%	2,253	3.14
Q3'25	7,078	+3.0%	3,357	47.4%	2,278	3.18
Q4'25 (derived)	about 7,008	n/a	n/a	n/a	about 2,164	about 3.03
Q1'26	6,517	+9.4%	2,953	45.3%	1,983	2.78
Q2'26	7,099	+3.7%	3,338	47.0%	2,362	3.32

Revenue growth is mid-single-digit. The +9.4% in Q1'26 is flattered by a weak Q1'25 comparison. TTM revenue is $27.70B.
Q2'26 operating income grew 3.3%, slightly below revenue growth of 3.7%. Operating margin slipped from 47.2% to 47.0%. Net margin still rose, from 32.9% to 33.3%, so the gain came below the operating line (interest, tax, or other). The data doesn't say which.
Q1'26 was the strongest quarter for profit. Operating income rose 11.5% YoY and EPS rose 6.9%.
EPS growth has been uneven: +1.6% in Q3'25, then +6.9% in Q1'26 and +5.7% in Q2'26.

5. Balance sheet (USD millions)¶

Item	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Total assets	59,920	60,037	59,515	60,608	59,555
Current assets	4,345	4,709	4,163	6,079	5,601
Current liabilities	4,018	4,146	4,361	6,079	4,298
Cash	822	1,170	774	2,413	1,876
Stockholders' equity	-1,023	-1,286	-1,791	-2,163	-2,760

Equity is shrinking toward zero. It improved from -$5.2B (Q3'24) to -$1.0B, though the quarterly gain has slowed to $263M in Q2'26. Equity could turn positive within a few quarters if the pace holds. The data doesn't separate the drivers, which could include retained earnings versus buybacks and dividends, or FX. A flip to positive would make P/B and ROE meaningful again, but it is mostly cosmetic.
Implied total liabilities are about $60.9B (assets minus equity). This is mostly debt and lease obligations, but the tool doesn't break it out. Leverage can't be assessed without the debt detail.
Liquidity is thin but normal for MCD. Cash of $822M is in line with prior lows ($792M in Q2'24 and $774M in Q4'25). The current ratio is 1.08. The company relies on operating cash flow and credit access, not a cash cushion.
The balance sheet is flat. Total assets are up only about 0.6% YoY.

6. Cash flow (USD millions)¶

Quarter	Op. cash flow	Capex	FCF (OCF − capex)	Financing CF
Q1'25	2,428	551	1,877	-1,543
Q2'25	1,998	744	1,254	-555
Q3'25	3,428	1,011	2,417	-1,786
Q1'26	2,412	682	1,730	-1,225
Q2'26	2,807	831	1,976	-2,387

Q2'26 operating cash flow was up 40% YoY ($2,807M vs $1,998M), and FCF rose about 58%. Q1'26 operating cash flow was flat YoY.
Cash conversion is high. OCF was 1.19x net income in Q2'26 and 1.22x in Q1'26.
Capex is rising faster than revenue. It was +27% YoY in Q3'25, +24% in Q1'26, and +12% in Q2'26. This is likely new-restaurant and reinvestment spending, but the tools don't confirm that. It trims near-term FCF but supports unit growth.
Q2'26 financing outflow was $2.39B, above FCF of $1.98B. Cash fell about $350M. The split between dividends, buybacks, and debt isn't broken out. Dividends are roughly $1.4B a quarter on my estimate, so about $1B went to repurchases and/or debt paydown.
Dividend coverage is about 1.1x on the vendor's $6.26B FCF (about $5.6B of annual dividends, derived). That is conservative, since TTM FCF is probably higher (see section 2). The payout is about 63% of GAAP EPS. The dividend looks sustainable, but there is limited room for large buybacks without more debt.

7. Insider transactions (Oct 2024 – Aug 2026, 90 records)¶

No open-market purchases appear anywhere in the dataset. Every record is a disposition. Most are sales, often paired with an option exercise, plus gifts and entries with no price or value. The no-price entries are probably award vesting or tax withholding, but the tool doesn't say.
Selling peaked in February 2026. Valued sales were about $24.0M in Q1'26, about $3.3M in Q2'26, and none with a reported value in Q3'26 so far.
The February 2026 sales were near the stock's peak. CEO Chris Kempczinski exercised 73,281 options at $128.09 and sold 52,553 shares at about $331–334 for $17.47M on 2026-02-13. That was about 73% of Q1'26 valued sales. CEO sales were not repeated in other months.
Other notable sales:
CFO Ian Borden sold 17,134 shares at $310 ($5.31M) on 2025-11-21.
Manuel Steijaert sold 13,134 shares at about $300 ($3.95M) on 2025-11-05, and 6,567 shares at $305.50 ($2.0M) on 2025-12-01.
Jonathan Banner sold 6,200 shares at about $333 ($2.07M) on 2026-02-23.
Edith Flatley sold 4,692 shares at $331 ($1.55M) on 2026-02-12.
Joseph Erlinger is the most frequent seller. He sells about 2,626 shares a month (after exercising $157.79 options) plus about 333 shares a month. The regular cadence looks like a pre-scheduled plan. His latest sale was 5,252 shares at $284.32 ($1.49M) on 2026-06-10. Desiree Ralls-Morrison sold 2,763 shares at $278.36 ($769K) on 2026-05-28.
Nothing has been reported since 2026-08-07. That entry is a 1,038-share disposition by Lauren Elting with no price or value. The last priced sale ($284.32) is about 19% above the implied current price.
How to read it: Most of the selling looks routine (option exercises, scheduled sales). It is not a distress signal. But the absence of any insider buying while the stock sits near its 52-week low is not a confirming signal for the bulls. The dataset lacks post-transaction holdings, so I can't tell what share of their stakes insiders sold.

8. Takeaways for traders¶

Supportive: - Steady EPS growth of 5–7%, operating margins of 46–47%, and cash conversion above 1.1x. - A 3.27% dividend yield, a low beta (0.45), and a lower multiple (19.4x trailing, 17.3x forward). - Revenue and EPS were both up YoY in each of the last three reported quarters.

Cautionary: - Q2'26 operating income grew slightly slower than revenue. - The forward EPS estimate implies growth of about 12%, well above the recent pace of 5–7%. - A PEG of 2.49 means the stock is not cheap on a growth-adjusted basis. - Capex is growing faster than revenue, and financing outflows exceeded FCF in Q2'26. - Leverage is high but unquantified here, and cash is low. - Price is below both moving averages. - There is no insider buying.

Next steps: 1. The Q3'26 report is the next catalyst. It has historically landed in late October or early November, but the tools give no date. 2. Look for comparable sales, traffic, and guidance. These explain the de-rating and aren't in my tools. 3. Pull debt, interest expense, and buyback detail to size leverage and coverage. 4. Watch the $229 low, which is the nearest support, and the $254 50-day average, which is the nearest resistance.

My fundamental read is neutral to constructive on the business and cautious on near-term sentiment. The trade decision is left to the next agent.

9. Summary table¶

Category	Key point	Data / evidence	Implication
Valuation	De-rated to 19.4x trailing and 17.3x forward	Implied price about $238 vs 52-week range $229.20–$341.75	Cheaper than February (about 27x), but PEG of 2.49 isn't cheap
Growth	Mid-single-digit EPS and revenue growth	Q2'26 EPS $3.32 (+5.7%), revenue $7.10B (+3.7%)	Forward EPS of $13.77 (+12%) needs acceleration
Profitability	Very high margins	Operating margin about 47%, net margin about 33% (Q2'26)	Strong franchise economics, but Q2 op. margin edged down 0.2 pt
Cash flow	Strong conversion, rising capex	Q2'26 OCF $2.81B (+40% YoY), capex $831M (+12%)	FCF is healthy, though capex growth trims it
Dividend	3.27% yield, payout about 63% of EPS	Coverage about 1.1x on vendor FCF (conservative)	Sustainable, with limited buyback flexibility
Balance sheet	Negative equity improving, thin cash	Equity -$1.02B (from -$5.2B in Q3'24), cash $822M, current ratio 1.08	Debt detail missing, so leverage can't be judged
Insiders	All sales, zero purchases	Q1'26 about $24.0M (CEO $17.5M at about $333), Q2'26 about $3.3M, none priced since	Routine selling, but no buying near lows
Technicals (context)	Weak trend	Price about 6% below 50-day and about 17% below 200-day average	Near-term sentiment is negative
Data gaps	Q4 columns missing, no liabilities or debt, FCF unreconciled	See section 2	Treat derived and vendor TTM figures with caution
Catalysts / watch	Q3'26 earnings, comps and traffic, debt and buybacks	Not in tool data	Needed to explain the de-rating

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for MCD: The Business Kept Compounding While the Multiple Got Crushed

I'll start with the point I expect the bear to attack hardest, then lay out why the case holds up anyway.

1. The stock fell 29%, but the earnings didn't¶

MCD is down about 28.8% from its February closing high of 334.50, to 238.31. Over that same stretch the reported numbers kept improving:

Q2'26: revenue rose 3.7% to $7.10B, net income rose 4.8%, and diluted EPS rose 5.7% to $3.32.
Three straight quarters of year-over-year growth in both revenue and EPS.
Operating margin of about 47% and net margin of about 33%. Few large-cap businesses earn these.
Cash flow is strengthening. Q2 operating cash flow rose 40% YoY to $2.81B, and free cash flow rose about 58%. Cash conversion runs 1.2x net income.

The P/E went from about 27x in February to 19.4x trailing and 17.3x forward. That is multiple compression, not an earnings problem. A business earning 47% operating margins with a 0.45 beta now trades at a lower multiple than it has in a long while.

2. The rates argument: the bear's best point, and it's mostly priced in¶

The 10-year is at 5.21%, and I won't downplay that. MCD is a bond proxy, and it got repriced like one. The yield went from 4.03% a year ago to a 5.31% peak on Oct 5, and the stock lost nearly 30%.

The earnings yield now roughly matches the 10-year. It is about 5.2% trailing and 5.8% forward, against 5.21% on the Treasury. The earnings stream grows 5–7% a year, and a Treasury coupon doesn't.
The dividend is about 3.1–3.3% ($1.86 per quarter). It is covered, with a payout of about 63% of GAAP EPS.
The timing lines up. The yield peaked at 5.31% on Oct 5, the same day MCD printed its intraday low of 229.20. Yields have since eased to 5.21%, and the stock has bounced about 4% off the low. That is correlation, not proof. But if the 10-year has crested, the pressure on MCD eases.
Hikes are consensus. Polymarket has an 82% chance of another hike and a 97% chance of no cuts in 2026. When everyone expects the bad news, it is largely in the price.

The same macro data also shows 4.2% unemployment, only 8% recession odds, and a VIX of 15. This is a rates problem, not a traffic collapse.

3. The moat matters most when the consumer is squeezed¶

CPI rose 0.65% in September, oil is near $103, and mortgage rates are close to 8%. That hurts weaker restaurant operators first. Wendy's is closing stores, Whataburger is retreating, Krispy Kreme is a "Bear of the Day," and Chipotle is volatile. MCD has the scale, the value positioning, and the franchise economics to take share when budgets tighten. Franchise rent and royalties are tied to sales, so menu inflation flows into the top line without MCD carrying all the cost pressure.

Rising capex (+12% YoY in Q2) is reinvestment in Restaurant NEXT and store changes. It is funded entirely from operating cash flow, with $1.98B of free cash flow in Q2 after capex.

4. The tape is showing early repair, though not a confirmed reversal¶

The primary trend is still down. Price is below a falling 50-day (about 253) and a falling 200-day (about 283). But under the surface:

RSI was oversold for 11 consecutive readings, hitting 21.8. It has since recovered to 43.7, with a higher RSI low on a nearly identical price low (230.94 vs 230.88).
MACD crossed above its signal line.
OBV made a higher low. At the same 238.3 price, volume balance is about 7.5M better than on Sept 23.
The 229–231 zone has held on five separate tests. The Oct 8 bounce came on 11.4M shares, the second-highest volume in the sample.
Weekly TD-9 is at +8, and the monthly z-score is -2.00, which is statistically stretched.
Today's close of 238.31 was also the day's high, and the highest close since Sept 22.

A move above 242.56 and then 250 would confirm it. The 50-day at 253 is about 6% above. The risk is defined by the 229–230 floor, roughly 8.5 points below, or 2×ATR. That is about 1.7:1 reward-to-risk to the 50-day.

5. Pre-empting the bear's other points¶

"Forward EPS of $13.77 needs 12% growth." That is fair, and it's my weakest spot. But if estimates miss by 5%, forward P/E is still only about 18x. Expectations are no longer priced for perfection.
"PEG of 2.49." PEG penalizes low-beta compounders. It doesn't capture a 47% operating margin, 1.2x cash conversion, and a 3%+ dividend.
"Zero insider buying." True, but the 90-record sample has no purchases even in strong periods, so absence isn't new information. The big sales (CEO at $331–334 in February) were near the peak, and selling has faded since. Erlinger's monthly sales look scheduled.
"Negative equity and thin cash." This is structural for MCD, and cash of $822M is in line with prior lows. Equity has improved from -$5.2B to -$1.0B.
"The Sept 23 gap-down." The 4.8% drop on 16.6M shares is unexplained in my data, and I won't pretend otherwise. But the last filing shows no deterioration, and the stock has now recovered to the post-gap close after dropping another 3%.
"Every bounce has failed." Yes, in June and July. But those rallies never came with oversold exhaustion, an OBV higher low, and a yield peak.

6. What the next few weeks decide¶

The Q3 report (date unconfirmed, historically late October or early November) and the late-October FOMC are the catalysts. After a 23% six-month drawdown, headlines are asking "Is the $8.5B fix priced in?" That skepticism is a better starting point than complacency. I'd watch comps and traffic, low-income consumer commentary, and the Restaurant NEXT spending plan.

I'd be wrong if MCD closes below 229.20, if yields break above 5.31% decisively, or if Q3 shows traffic deteriorating.

My question for the bear: MCD earned more this quarter than a year ago, produced 40% more operating cash flow, and trades at 17x forward earnings, down from 27x. If a ~5% earnings yield and a growing dividend aren't enough at the lows of a stretched selloff, what multiple would you pay for this franchise? Bull Analyst: # Bull Rebuttal: The Bear Is Pricing a Rate Problem as a Business Problem

You landed several real hits, so I'll concede them first:

"Three straight quarters" means three reported YoY comps, because Q4'25 is derived.
The +40% operating cash flow (OCF) is mostly a base effect.
Forward EPS of $13.77 is my weakest number.
MACD crossed while still below zero.
The Sept 23 gap is unexplained.
My 5.31% yield invalidation is close.

None of these changes the conclusion. Some of your rebuttals also reverse once you use half-year data.

1. On a half-year basis, the cash flow story holds¶

You called the OCF jump a base effect. I agree, so I'll use H1 instead (USD millions, from the tables):

H1	2025	2026	Change
Net income	4,121	4,345	+5.4%
Operating cash flow	4,426	5,219	+17.9%
Capex	1,295	1,513	+16.8%
Free cash flow	3,131	3,706	+18.4%
Financing outflow	2,098	3,612	+72%

Capex isn't outrunning cash flow. Capex is 29.0% of OCF in H1'26 versus 29.3% in H1'25. The +27%, +24%, +12% sequence is decelerating, and over H1 capex grew slightly slower than OCF.
The Q2 financing outflow was timing. Q2 alone ($2.39B) exceeded FCF, but H1 financing ($3.61B) was covered by H1 FCF ($3.71B). Cash rose from $774M to $822M over the half.
The dividend has room. At $1.86 a quarter on roughly 707M shares (market cap ÷ price, my arithmetic), dividends run about $1.3B a quarter. H1 FCF covers that about 1.4x, with roughly $1B left for buybacks and debt.
Q3 will look soft on the comp. It laps $3.43B of OCF. If the YoY print is weak, that is the calendar, not a thesis break.

2. The growth is steady, not decelerating¶

EPS growth went +1.6% in Q3'25, then +6.9% in Q1'26, then +5.7% in Q2'26. That is an improvement from the Q3'25 low, not a fade.

Two-year revenue stacks. Q1 is about +5.6%, as you noted. Q2 is 1.054 × 1.037, or about +9.3%. The most recent quarter has the better two-year stack.
Margins held. Operating margin moved from 47.2% to 47.0%, which is flat in practice. A real traffic problem at a business with this much operating leverage would show up in margin. It didn't.
Per-share growth reaches owners. You're right that about 0.9 points of EPS growth came from share count. That is the buyback the financing line funds.
I can't fully explain the below-the-line gain. Operating income grew 3.3% and net income 4.8%. It stays on my Q3 checklist.
Revenue tracking inflation can be a feature. If CPI is about 3.7% (the headline you couldn't verify), the 10-year is paying roughly 1.5% real. MCD's cash flows reprice with prices. A Treasury coupon doesn't.

3. "Zero equity risk premium" ignores growth¶

A trailing earnings yield of 5.17% against 5.21% treats MCD as a no-growth perpetuity. A better back-of-envelope is dividend yield plus growth:

Dividend yield of 3.1–3.3%, plus 4% growth (inflation-ish) gives about 7–7.5%.
Dividend yield plus 5.7% (the recent EPS pace) gives about 9%.
That is roughly 2–4 points over the 10-year. It is thin, but not zero, and it comes with a 0.45 beta.

This is an assumption-driven estimate, not a forecast. Your $209 BofA illustration has the same flaw. Capitalizing $12.31 at 5.9% is the price if earnings never grow again.

4. Rates: an invalidation 10bp away is the point¶

A level close to the market is a feature in risk management.

I'm not claiming the 10-year has crested. The bull case needs rates to stop rising, not fall.
Hikes are consensus. The 82% "another hike" odds are the base case. The tail you cite, "exactly three," is an 18% contract on thin volume.
The yield ladder fits the lower lows. The yield was 4.03% a year ago, 4.72% in mid-August and 5.31% on Oct 5. The stock fell from 258.22 (Aug 27) to 229.20 (Oct 5), roughly 11%, while yields rose about 60bp. I lack the May yield, so I only claim the last leg. The market was discounting a higher discount rate.
A dull macro still lets MCD compound. You said macro removes both ways MCD could rally. But with flat rates, the dividend plus about 5–6% earnings growth is a high-single-digit return with no catalyst.

5. Traffic and the Sept 23 gap: unproven both ways¶

You're right that no tool has comps, traffic or guidance, and that the last filing predates the gap. I can't close that, and Q3 traffic deterioration is on my invalidation list.

The burden is symmetric. The gap is unexplained, so it isn't evidence of traffic weakness any more than of rate repricing.
The only hard data is benign. Revenue is up 3.7%, margin is flat and cash conversion is 1.2x, while Wendy's closes stores.
Managers also invest from strength. The marketing reset and remodels are being paid for within H1 cash flow.
The "value leader" tension is real. Price increases and value positioning pull against each other, and the Q3 comp-versus-traffic split tests it.
Post-gap selling is fully retraced. Today's 238.31 equals the post-gap close of 238.32. The gap itself (250.35) is not recovered.

6. The tape: early, and I'm sizing for it¶

OBV. You're right that a 7M higher low against a 100M decline is small. But 27M came back in ten sessions, after a roughly five-week slide. That is repair, not healing.
TD-9. Completing a weekly 9 requires a lower close by construction, and it is a buy-setup exhaustion signal. I treat it as context, not a trigger. The monthly z-score of -2.00 is the sturdier stretch gauge.
Risk/reward. The 50-day is falling toward price (about 0.6 a session), so the reward leg shortens as the target gets more reachable. The Sept 23 gap shows stops can slip. That is a sizing answer: size so a 12-point gap through the stop is survivable.
Support. A break of 229.20 leaves no structure below, so I'd exit and not average down.

7. Insiders and leverage¶

The CEO sale. Exercising 73,281 options at $128.09 cost about $9.4M, over half of the $17.5M proceeds, before taxes. It was an exercise-and-sell, not a conviction call. The data has no post-sale holdings.
Interest coverage can be bounded. Q2 operating income was $3,338M and net income $2,362M. If taxes were zero, interest and other items could be at most $976M, so coverage is at least 3.4x. At a tax rate of 18–22% (not in my data), it is roughly 7–11x. This assumes little else sits between those lines, and leverage itself remains unmeasured.

8. Your price and your triggers conflict¶

Your valuation rule is a 6–6.5% trailing earnings yield, which means $190–$205. That is 14–20% below today and well below the 52-week low of $229.20.

But your list of evidence that would change your mind includes a close above $253 with RSI above 50. At $253 the earnings yield is 4.87%, even less attractive by your own rule. Which is your real rule?

The spread framework also implies the 10-year would need to be near 4% for $238 to work. That is last year's level.

Where this leaves us¶

You want 15.5–16.5x TTM earnings. The market pays 19.4x, or about 18x on your own growth-adjusted EPS. The gap is two to three turns, about 15–20%. You need rates to keep rising for MCD to reach your price, and then you would want to buy.

My case needs less: the 10-year stops rising, Q3 traffic isn't worse than the Q2 numbers imply, and earnings keep compounding at 5–6%. I'm wrong if MCD closes below 229.20, if the 10-year breaks decisively above 5.31%, or if Q3 shows traffic deterioration.

The biggest holes I can't close are the unexplained gap and the unverified forward EPS. Bull Analyst: # Bull Closing: We Now Disagree About Timing, Not Value

The biggest shift in this debate is that you moved from "15–20% rich" ($190–205) to "$238 is roughly fair at today's 10-year." What remains is event risk and a stress-case entry price. I'll concede what you earned, then show why that remainder doesn't justify staying out.

Conceded: - Cash flow: The 9M math is right. Q3'26 OCF will likely print below Q3'25's $3.43B, and I shouldn't call cash flow "accelerating." My claim is that it is covered. - Traffic: "Rates problem, not a traffic problem" is my base case, not a fact. Nothing in the data tests it before Q3. - Margin: Flat margin fits a traffic story as well, because price can hold revenue and margin while franchisees absorb the damage. - One bet, not three: The 5.31% yield invalidation and the 229.20 price invalidation are the same trade. - Beta: A 0.45 beta is the wrong comfort for a rate-driven selloff. - Growth rate: Underlying EPS growth is about 4–4.5%, and the 5.7% headline includes 1.5 points I can't explain. I'll use 4–5%. - Sentiment: 8:1 bullish on n=9 in one session is noise, and it doesn't support either of us. - Reward target: The falling 50-day is a decaying target. I'll use a fixed one below.

1. Your own table is two-sided¶

Your table gives $197–207 at a 5.9% yield and $260–281 at 4.72%. That is roughly −13% to −17% against +9% to +18%. You read the left side as the risk. But 5.21% already embeds the "another hike" odds (82%, thin volume), and surprises move yields in both directions.

If $238 is fair, your model's expected return is the required return: about 7.25% at g=4%, or about 8.3% at g=5%. That is 2–3 points over the 10-year. So "stay out" is a timing preference, not a valuation call. Your entry at $200–210 is your own stress scenario, a 5.9% 10-year. Waiting for it is a macro bet that yields spike. It is not a view that the business is overpriced.

Your neutral triggers have the same problem. Positive Q3 comps, a 10-year near 5.0%, or a close above $253 would all arrive with a higher price. You've said you wouldn't buy at $253 on valuation either. In practice, that means "only buy if the stress case happens."

For scale, ATR of 4.24 is about 1.8% of price. Over the roughly 15 sessions to the FOMC and the print, that is around 7% (√15 × 1.8%). ATR overstates close-to-close volatility, so treat this as a rough ceiling. A 12–16% "event discount" is about twice the typical three-week range.

2. You're right that I need falsifiers, so here are numbers¶

You said my thesis can only be tested by events two to three weeks out. Those events are the test, and I'll pre-commit to thresholds. These are my judgment, anchored to the Q3'25 comps (revenue $7,078M, operating margin 47.4%, EPS $3.18):

Revenue: growth below about 2.5%. That would put the two-year stack under Q1'26's +5.6%.
Margin: operating margin below about 46.0%, which is 140bp of compression against a 20bp slip in Q2.
EPS: below $3.18, meaning negative YoY.
Traffic: US comps negative, or franchisee-profitability commentary deteriorating. This is the test of your "price masks traffic" point.
Capex: guidance that breaks the dividend-coverage line below.
Price: a close below 229.20.

3. Capital allocation: buybacks give first, the dividend doesn't¶

Your "no slack" figure is right. H1 FCF after dividends was about $1.08B against about $0.98B of non-dividend financing. That also means the company funded itself, and cash rose $48M over the half. The data doesn't split financing, so which item flexes is an assumption on both sides. Here is what a capex step-up does with OCF held flat at $5,219M and dividends at about $2.63B (my estimate: $1.86 × 2 × about 707M shares):

H1-equivalent capex	FCF	Dividend coverage	Left after dividends
$1,513M (actual)	$3,706M	1.41x	$1,076M
+20%	$3,403M	1.29x	$773M
+50%	$2,949M	1.12x	$319M
+71%	$2,630M	1.00x	$0

So capex can rise about 70% before FCF stops covering the dividend. The buyback is what gives first, which is your point. But losing the buyback costs about 0.9 points of EPS growth, which leaves growth near 4%. That is already the base case in your D+g model, and it still yields $238. The $8.5B "fix" is a headline with no body text. If it implies capex well above +70%, the thesis breaks and I'm out.

4. Two cautions on the rate math¶

Duration: The Gordon model holds g at 4% while the 10-year rose 118bp in a year. Revenue growth of 3.7% suggests some inflation pass-through already lands in the top line, so true duration is probably below 30. The observed ladder (about 18) is the better guide, and it is two-sided.
Flattening: The 10s–2s spread fell from +0.51% to +0.37% while the 10-year sits 10bp under its peak. The front end is carrying the repricing, and the long end that sets MCD's discount rate hasn't re-broken higher. I can't separate the two legs without the Oct 7 10-year yield, so this is context, not proof.

5. Risk/reward, restated honestly¶

I'll use a fixed target, the 250.35 pre-gap close. That is 12.0 points of reward against an 8.5-point 2×ATR stop, or about 1.4:1. That is decent, not exceptional. A gap through the stop to about 217 is a 21-point loss (about 9%), so sizing has to assume that. The chart is not my thesis. The thesis is roughly 7–8% expected return with a 3%+ dividend, at a price you call fair. The daily TD sell count could complete around Oct 20, which would make a pullback toward 231–234 an add zone, not an exit.

6. The gap is still the biggest hole¶

You calculated that a 4.8% drop equals a 20–25bp move in the 10-year in one session. Neither of us checked yields on Sept 23. That check is cheap, and it matters because it separates a rates explanation from a company-specific one. Until it's done, I wouldn't size up.

Where this leaves us¶

Plan: Take a starter position, not a full one. Add after Q3 clears the thresholds above, or on a close above 242.56 with the print in hand.
Exit: A close below 229.20, a Q3 miss on the thresholds above, or capex guidance that breaks dividend coverage. I won't average down.
Sizing: Assume a 9% gap-through loss.

My case needs less than yours. It needs the long end to stop rising, Q3 to avoid showing traffic deterioration, and earnings to compound at 4–5%. You've agreed that this is worth about today's price. You are asking for a 12–16% discount to cover three weeks of event risk. I'd pay a smaller starter position instead and keep the option to add once the print answers the question neither of us can answer today. Bull Analyst: # Bull Close: A Thin Edge, Sized to Match

We agree on more than most debates allow. You accept that $238 is roughly fair at a 5.21% 10-year, that the dividend is covered, and that my falsifiers are specific. Three questions remain:

Is my growth assumption too generous?
Does three weeks of event risk justify waiting?
Are my exits tight enough?

You were right on parts of the third.

Conceded - Add zone: The 231–234 add zone contradicts "I won't average down," so it's dropped. - Traffic exit: "US comps negative" is a weak traffic bar when price can prop up comps. "Franchisee-profitability commentary" isn't a threshold, so I'm removing it. - Carry: Three weeks of carry is about 0.4%, so in the short run this is a bet on two events. - Cushion: The cushion over the 10-year is thin, 1–2 points depending on g. I'm not claiming a margin of safety. - Framing: "Rates, not traffic" is a base case, and your duration math shows why.

1. The growth floor doesn't depend on the unexplained 1.5 points¶

Your 4.2% starts from one quarter's operating income (+3.3%). On the half-year window we both accepted for cash flow:

H1	2025	2026	Change
Revenue	12,799	13,616	+6.4%
Operating income	5,880	6,291	+7.0%
Net income	4,121	4,345	+5.4%
Diluted EPS	5.74	6.10	+6.3%

H1 is flattered by an easy Q1'25 base (revenue −3.5%), so I'm not using 6%. But 4–5% is already a haircut, not a stretch. Your 3.3%-with-zero-buyback case gives a 6.5% required return, 1.3 points over the 10-year. That is the worst case I'd accept, not the base.

On the buyback, a dollar spent at $238 retires about a quarter more shares than at $300. The 0.9% share-count benefit came at higher prices, so a smaller buyback loses less accretion than the headline suggests. If the capex step-up is the growth investment it's meant to be (the tools don't confirm this), part of the shortfall converts into earnings growth instead of vanishing.

2. The swing is variance, and waiting has a price¶

Fair enough on the arithmetic: carry is about 0.4% against a roughly ±7% ceiling on the swing. But if neither of us has an edge on the events, the swing has zero expected value and the carry is positive. What remains is a variance question, and position size handles variance.

Your triggers also have a price. Using our two rough models, a 10-year back near 5.0% implies about $247 on the ladder and about $255 on D+g at g=4% with the same spread. Waiting for your cleanest trigger means paying roughly 4–7% more than today. You said you'd pay that for information, and that is a coherent choice. Mine is to own a small slice of the exposure and keep the option to add.

You're also right that a Q3 pass doesn't create the rally. The thesis has two legs: 1. The business holds, which Q3 can test. 2. The long end stops rising, which Q3 cannot test.

Leg two is what makes money, and I have no edge on it. That is why this is a starter.

3. Revised plan¶

Item	Rule (my judgment, not a model output)
Entry gate	Check the 10-year change from Sept 22 to Sept 23. If it moved less than about 10bp, I treat the gap as company-specific and wait for Q3.
Traffic exit	Exit if reported or management-described US guest counts are negative, even if comps are positive. If traffic isn't disclosed, I don't add.
P&L falsifiers	Revenue growth below about 2.5%, operating margin below 46.0%, or EPS below $3.18.
Capex/FCF	Guidance that pushes FCF coverage of the dividend toward 1.0x.
Price exit	A close below 229.20, with no averaging down.
Adds	Only after Q3 clears the thresholds or a close above 242.56. None below entry.
Size	Sized so a roughly 9% gap-through (about $217 fill) costs a small fraction of the portfolio. At an illustrative 5% weight, that is about 0.45%.

4. The gap decides whether I start¶

Your duration split is the honest version of the problem: - Duration 18–19: rates explain nearly all of the 11% decline from Aug 27 to Oct 5. - Duration 10: about 5 points are company-specific, roughly the size of the Sept 23 gap.

I can't tell which holds without the gap-day yield. My tools can't pull it in this format, but it is a one-line FRED lookup (DGS10, Sept 22 vs Sept 23). It belongs before any order. A 4.8% gap equals about 25bp on the ladder, so a move near that size supports rates and a flat day points to the company.

5. Hit rate¶

Your break-even rates of about 42% (8.5-point stop) and about 64% (21-point gap-through) check out. I'm not running this as a trade for a 12-point bounce. The 229.20 level is where the thesis is invalidated, and sizing is what makes a gap-through survivable.

Where this leaves us¶

	Bear	Bull
Price	Fair at 5.21%	Fair at 5.21%
Edge on Q3/FOMC	None	None
Action	Stay out until about $200–210, or a clean Q3 with the 10-year near 5.0%	Gated starter, tight exits, no adds below entry
Cost	Pay about $247–255 on a clean confirmation, or wait for the 5.9% stress case	Carry ≈ 0.4% over three weeks against a symmetric swing

My claim is modest. A franchise with 47% operating margins and 4–6% earnings growth, bought at a few points over the risk-free rate with a 3%+ dividend, justifies a small position. The condition is that the business holds and the long end stops rising.

A question for the bear: if the Sept 23 check shows a rate move of 20bp or more, which would mostly explain the gap, would you move from "stay out" to "starter," or does the 5.31% yield level remain the blocker?

Open items: the gap-day yield, forward EPS of $13.77 (possibly adjusted versus GAAP), and the FOMC and Q3 dates remain unverified. All rate attributions here are approximate. Bull Analyst: # Bull Close: Same Price, Same Ignorance, Different Risk Budget

You've narrowed this to one branch. If the Sept 23 check shows that rates explain the gap, you'd start after the FOMC and I'd start before it, at half size. In the other two branches we agree to wait for Q3.

Conceded - Buyback wording: My sentence was muddled. The corrected version is in section 2. - Falsifiers: They are "don't break" tests. A Q3 EPS of $3.18–$3.31 clears all of them and could still disappoint a street number I haven't seen. My price stop covers that risk, not my P&L thresholds. - Traffic exit: It has a hole when traffic isn't disclosed. I fix it in section 3. - Leg two: If rates explain the gap, "the long end stops rising" is the whole thesis. The 19–24 duration estimate is only as good as the unverified gap-day yield. - The gate: A yield move alone isn't enough, since 16.6M shares is about 3x normal volume. I adopt your two-part test, with the 10-year change plus the move in YUM and staples.

1. Waiting is a variance trade, not an expected-return trade¶

We both say we have no edge on the FOMC or Q3, and we both call $238 roughly fair. Under those premises, the two strategies compare like this:

Tail outcome by the FOMC (rough, from our two models)	Hold a starter	Wait for confirmation
10-year drifts to about 5.0%	Gains roughly 4–7%	Buys 4–7% higher, with the same go-forward return
10-year pushed toward 5.9%	Loses roughly 13–17%	Avoids it
Middle outcomes	Collects carry (~0.4%)	Collects nothing

If price is fair going in, the post-event price already reflects the outcome. Buying after a clean FOMC earns the required return from there, no more. Buying now earns the same, plus the 0.4% carry over the window. The 4–7% you'd pay in the good branch and the 8–11% you'd avoid in the bad branch offset each other in expectation. You said yourself that passing a test "doesn't create the rally."

So the real price of waiting is the variance you remove. That is a legitimate preference, but it is a sizing question and not a view that the business is overpriced. At an illustrative 2.5% weight, a 9% gap-through costs about 0.22% of the portfolio.

The one way waiting beats holding on expectation is trend persistence. The lower highs and lows run from March to October, and the 50-day sits below the 200-day. That is a real view, but you haven't argued it as an edge. The weak counter-evidence (OBV higher low, RSI divergence, monthly z-score of -2.0) points the other way, so I'd call it a draw.

2. The buyback arithmetic, corrected¶

You're right that cutting a dollar of buybacks costs more accretion at $238 than at $300. What I should have said is that the lower price offsets a dollar cut of up to about 20% (1 − 238/300), assuming roughly $300 average repurchase prices.

Your own capex table shows what that means, with OCF flat and cash held flat. All of this assumes the $982M non-dividend bucket is all buybacks, which the data doesn't split.

Capex step-up	Non-dividend outflow cut	Buyback accretion (from ~0.9 pts)	Required return (g = 3.3% + accretion)	Spread over 10-year
+20%	about 21%	about 0.9 pts (price offsets the cut)	about 7.2%	about 2.0
+50%	about 68%	about 0.4 pts	about 6.9%	about 1.7
Any, no buyback	n/a	0	about 6.5%	about 1.3

I'm crediting no return on the capex itself. These are framework outputs, not forecasts. The spread thins as the buyback shrinks, but it does not go to zero at any step in your table. So the dividend and a 3.3% earnings base still leave a 1.3–2.0 point cushion. I'd call that thin, not absent.

3. Revised plan¶

Item	Rule (my judgment, not a model output)
Gate	Run the check before any order. Compare the 10-year change from Sept 22 to Sept 23 (DGS10) and the same-day moves in YUM and staples.
Rates branch (≥ ~20bp and peers down)	Enter half the starter before the FOMC. Enter the other half after it, only if the 10-year hasn't closed above 5.31%.
Mixed or company-specific branches	Wait for Q3, as you proposed.
Traffic exit	Exit on negative disclosed guest counts. If counts aren't disclosed, treat US comps at or below the cited menu-price increase as negative traffic. If neither is disclosed, halve the position.
P&L falsifiers	Revenue growth below ~2.5%, operating margin below 46.0%, or EPS below $3.18.
Tape risk	If the print clears the thresholds but the stock closes below 229.20, I exit. The price rule overrides the P&L rule, and the 9% gap-through is already in the sizing.
Capex/FCF	Exit on guidance that pushes dividend coverage toward 1.0x.
Adds	None below entry. Add only after Q3 clears the thresholds or on a close above 242.56.

Where we land¶

	Bear	Bull
Price at 5.21%	Fair	Fair
Edge on FOMC/Q3	None	None
Gate	Two-part, agreed	Two-part, agreed
If the gap was rates	Starter after the FOMC	Half before, half after
If not	Wait for Q3	Wait for Q3
What each pays	A 4–7% higher entry in the clean branch	About 0.22% of the portfolio in a gap-through, plus FOMC variance

My case is modest. MCD is a franchise with 47% operating margins, 4–5% earnings growth, and a 3.1% covered dividend. At fair value it earns a required return 1.3–2.0 points over the risk-free rate. A small position with hard exits can sit on that edge, and a clean Q3 and a calm long end are what let it compound. It does not rest on the chart, and I'm not claiming a margin of safety.

I'm wrong if: - MCD closes below 229.20. - The 10-year breaks decisively above 5.31%. - Q3 breaks the P&L thresholds or shows negative traffic. - Capex guidance breaks dividend coverage.

Open items: the gap-day yield and peer moves, forward EPS of $13.77 (adjusted vs. GAAP, and its fiscal basis), the FOMC date (Oct 27–28 is a recollection), the Q3 date and consensus, and the split of financing outflows between buybacks and debt. The rate attributions and the buyback table are approximate.

Bear Researcher¶

Bear Analyst: # Bear Case for MCD: The Multiple Was Never the Whole Problem

You asked what multiple I'd pay, and I'll answer at the end. First, your core framing has some problems.

1. "Earnings kept growing" is the problem, not the defense¶

MCD printed growth in Q1 and Q2 and still made lower lows after both: 270.83 in May, 258.22 in August, 230.88 in October. If good reported numbers can't hold the stock up, the market is discounting something the trailing numbers don't show. Looking closer at the numbers:

"Three straight quarters" has a hole in it. The quarters are Q3'25, Q1'26 and Q2'26. Q4'25 is derived and has no YoY comp. Q3'25 EPS grew only 1.6%.
Q2 operating income grew 3.3%, slower than revenue at 3.7%. Margin slipped from 47.2% to 47.0%. The EPS beat to 5.7% came from below the operating line and about 0.9% from a smaller share count.
Q1's +9.4% revenue is flattered by a -3.5% comp. Over two years that is about +5.6%.
Revenue growth is roughly inflation. Nominal revenue is up 3.7% while a headline cites CPI at about 3.7% YoY, which I couldn't verify against FRED. That implies little or no real growth.
The +40% operating cash flow (OCF) is a base effect. Q2'25 was the weakest OCF quarter in the table ($2.0B), and Q1'26 OCF was flat. First-half OCF is up about 18%, which is respectable, but it isn't a 40% trend. Q3 now laps the strongest quarter in the table, with $3.43B OCF and $2.42B FCF.
Capex has outgrown revenue in every reported quarter (+27%, +24%, +12%). Q2 financing outflow ($2.39B) exceeded FCF ($1.98B), and cash fell $350M.

2. The valuation math doesn't work on a like-for-like basis¶

Your 17.3x forward P/E uses $13.77 of EPS, which is 12% above TTM GAAP. That gap may be partly an adjusted-versus-GAAP mismatch. If so, your 5.8% forward earnings yield isn't comparable to a GAAP trailing figure. Growing from $12.31 at the recent 5.7% pace gives roughly $13.00, or about 18.3x.

On the cleanest number, the trailing earnings yield is 5.17% against a 5.21% Treasury. That is a zero equity risk premium for a business with $60.9B of implied liabilities and an unquantified debt load. The dividend yield is 3.27%, nearly 2 points below the risk-free rate. PEG is 2.49. The 27x you call the anchor was one approximate February data point, not a fair-value reference.

An illustration, not a forecast: BofA's survey says managers won't rotate from stocks to bonds until yields reach about 5.9%. If MCD's trailing earnings yield simply matched that, $12.31 / 0.059 implies about $209, roughly 12% below today.

3. Rates are not "priced in," and your invalidation level is 10bp away¶

You said you'd be wrong if the 10-year breaks above 5.31%. It's at 5.21%. Meanwhile:

September CPI was +0.65% m/m, and October CPI lands in mid-November.
Polymarket has 82% odds of another hike, with "exactly three" up 7.5pp this week.
The 10s-2s spread compressed from +0.51% to +0.37% in a week, so the front end is repricing hawkishly.
One 10bp pullback from the peak isn't a crest. You flagged the timing as correlation, not proof, and I agree.

Your own macro data also removes both ways MCD could rally. A recession flight to safety is 8% likely, and rate cuts are 3% likely. A stagflation-lite world with a 97% chance of no cuts, oil at $103 and a calm VIX of 15 is the one where a bond proxy has no catalyst.

4. "It's a rates problem, not a traffic problem" is unsupported¶

No tool in this debate has comps, traffic or guidance. Nobody can say it isn't a traffic problem.

The Sept 23 gap is the biggest tell. It was -4.8% on 16.6M shares, the highest volume in the 252-session sample, and nobody can explain it. You say the "last filing shows no deterioration," but that filing covers the quarter ended June 30, almost three months before the gap.
The company's own actions suggest it sees a traffic issue. The headlines are a marketing reset to "improve customer engagement and sales," major store changes "to attract more customers," and an "$8.5B fix." These are headlines only, with no article text.
"Value leader" and "menu inflation flows through" pull against each other. You can't take share on value while also relying on price increases to drive the top line.
The peer news cuts both ways. Wendy's closures and Krispy Kreme point to a soft category. If MCD were taking share, we'd expect to see it in the numbers, and we don't have them.

5. The tape is a bounce inside a downtrend¶

OBV: It fell from +29.1M to -71.7M, about 101M shares of net distribution. The bounce has recovered 27M of that, or about 27%. A 7M higher low against a 100M decline is small.
MACD: The crossover happened at -4.97, below zero. RSI is 43.7, below 50.
Support: The five tests of 229–231 came within eight sessions, so it is one base, not five confirmations. It is also the lowest price in the sample, so a break would leave no prior structure below.
TD-9: The weekly +8 only completes to a 9 if the week ending Oct 23 closes below 236.50. That needs a lower close, not a higher one. A daily sell setup could complete around Oct 20.
Risk/reward: Your 1.7:1 targets a falling 50-day. It has dropped about 13 points in a month. A 2×ATR stop is 8.5 points, and the Sept 23 gap was 12 points in one session. The risk is not defined.
Overhead: $240 is already cited as resistance, and the pre-gap area near 250 sits under the 253 50-day.
Sentiment: StockTwits has 8 bullish and 1 bearish among labeled posts (n=9), "bottom is in" calls, and put-holder taunting after one up day. That reads as bounce euphoria, and the news flow is more cautious.

6. Insiders and the balance sheet¶

You're right that Erlinger's monthly sales look scheduled, and I won't push that. But the CEO's $17.5M sale at $331–334 was 73% of Q1's valued sales, right before a 29% drawdown. There has been no buying at the lows. I'd call it neutral at best. The shrinking negative equity is mostly cosmetic, and interest coverage and net debt can't be computed from this data. That is exactly what matters when the 10-year is at 5.2%.

My answer to your question¶

I wouldn't pay a particular multiple. I'd pay a spread over the 10-year. Wanting about a 6–6.5% trailing earnings yield, roughly 15.5–16.5x TTM EPS, puts fair entry around $190–$205. That is my judgment, not a model output.

At $238, I'd need evidence instead:

Fundamentals: Q3 shows positive US comps and traffic.
Rates: The 10-year moves decisively back toward 5.0% or lower.
Price: A close above the 50-day (about $253) with RSI above 50.

Until then, this is an oversold bounce into falling resistance. The macro catalyst points the wrong way, and the next real data points (the FOMC, Q3, and October CPI) are all binary. I'd stay out. Bear Analyst: # Bear Rebuttal: Fair Value at Today's Rates, With No Cushion for Tomorrow's

You scored on several points. I'll concede them, then show where the case still breaks.

Conceded: - H1 is a fairer window for cash flow. OCF +17.9% and FCF +18.4% are real, and your 3.4x coverage floor settles solvency for me. - Q2's two-year revenue stack (+9.3%) beats Q1's (+5.6%). It is your best growth number. - The CEO sold 52,553 of the 73,281 shares he exercised. I'm dropping insiders as a bear point. - My 6–6.5% earnings-yield rule ignored growth. I replace it below, and my number moves up. - The $253/RSI>50 item was a "stop being bearish" tripwire, not a value signal. I wouldn't buy at $253 on valuation either.

1. H1 smooths the base effect and you've pre-excused the next print¶

Q1'26 OCF was down 0.7% YoY ($2,412M vs $2,428M). The whole H1 gain is Q2 against the $1,998M trough. Nine months is the cleaner test. 9M'25 OCF was $7,854M. - If Q3'26 matches Q2 ($2.81B), 9M OCF is up about 2%. - If it matches the record Q3'25 ($3.43B), it is up about 10%. - Holding +18% would need about $4.04B, 18% above the best quarter in the table.

So the "accelerating cash flow" story rolls over on the next print, and you've already filed that under "calendar, not a thesis break." You've done the same with forward EPS ("weakest number"), traffic ("can't close"), the gap ("can't close") and the below-the-line gain ("on my checklist"). Your thesis can only be falsified by an event 2–3 weeks away.

On capital allocation, H1 FCF after about $2.63B of dividends is roughly $1.08B. Non-dividend financing was about $0.98B, so there is no slack. Capex grew 16.8% against H1 revenue growth of 6.4%. If the "$8.5B fix" (headline only) steps spending up, something gives. Either the buyback goes, and your 0.9 pts of EPS growth lives there, or the balance sheet takes on 5%+ money. "That is the buyback the financing line funds" is an assertion, because the data doesn't split financing.

2. Growth decelerated, and margin isn't your traffic detector¶

On a one-year basis, every line slowed from Q1 to Q2: - Revenue: 9.4% → 3.7%. - Operating income: 11.5% → 3.3%. - EPS: 6.9% → 5.7%.

Operating income growth (3.3%) plus share count (about 0.9%) gives roughly 4.2% underlying EPS growth. The other 1.5 pts of the 5.7% headline came from below the line, and neither of us can explain it. Your 4% base case is fine. The 5.7%-based "9%" return isn't.

You said a real traffic problem "would show up in margin." Your opening said franchise rent and royalties are tied to sales, so menu inflation flows into the top line. Price can then hold revenue and margin while traffic erodes, and the damage lands first on franchisee profitability, which isn't in this data. Flat margin fits both stories.

3. The rate math in your own framework¶

Using your dividend-plus-growth framework (g = 4%, $7.44 dividend), today's price implies a required return of about 7.25%, or 2.04 pts over the 10-year. I then re-priced it two ways. One is a stylized constant-growth model with full pass-through of the yield change. The other is your own empirical ladder, where the stock fell about 11% on about 60bp of yield.

10-year yield	Your ladder (~11% per 60bp)	D+g model
4.72% (mid-Aug)	~$260	~$281
5.21% (today)	$238	$238
5.90% (BofA threshold)	~$207	~$197

Both are rough, and the ladder overstates rate attribution if the gap wasn't rates. The 5.9% case is a stress scenario, not a forecast.

Duration: This implies an equity duration of roughly 19–30 years, against about 8 for the Treasury note you're comparing it to.
Beta: You cite the 0.45 beta as comfort. MCD fell 29% with the VIX at 15. Beta measures the wrong risk factor, and this episode proves it.
Payoff: The upside needs yields to fall. Polymarket has cuts at 3% and recession, the usual route to lower yields, at 8%.
One trade, not three: The 5.31% yield peak and the 229.20 low were the same day, Oct 5. A 10bp move is worth about 2–2.5%, which is roughly $232–234. Your yield stop and price stop are one bet.

4. The "benign" data ends June 30, and the gap is not symmetric¶

The last filing predates the gap, and Q3 closed on Sept 30. Since late June the stock has gone from the $260–280 range to $238. The market has traded Q3 for three months, and the record-volume session came a week before quarter-end.

I agree the burden is symmetric. That means "this is a rates problem, not a traffic collapse," your opening line, isn't a fact either.

On your own sensitivity, a 4.8% gap equals a 10-year jump of roughly 20–25bp in one session. That would be a third to 40% of the whole 59bp climb since mid-August, in a day. It's possible and checkable, and neither of us checked.

The stock has also round-tripped: 238.32 on Sept 23, 230.88 on Oct 7, and 238.31 today. Three weeks, record volume and a new low have left it flat. The $12 gap is unrecovered.

5. Risk/reward and the tape¶

Gap-adjusted R:R: You said to size for a 12-point gap through the stop. A fill near 217 means a loss of about 21 points against 14.7 to the 50-day, or 0.7:1, not 1.7:1.
Reward decay: The 50-day falls about 0.6 a session. After ten flat sessions it's near 247, so the reward is about 8.7 against an 8.5 stop, or 1:1. "More reachable" means less reward.
Sentiment: The sentiment report shows 8 bullish to 1 bearish (n=9), "bottom is in" posts, and put-holder taunting after one green day. Retail is more bullish than the news flow. That is a late-bounce signature.
Overhead: $240 and 242.56 sit directly above price, and the daily TD sell count (−5) could complete around Oct 20.

Where this leaves us¶

You asked which rule is real. The trigger list was for when I'd stop being bearish. The price is a separate question.

Here is the revised price. At today's 10-year, $238 is roughly fair. I'm no longer calling it 15–20% rich. That is the problem: - A 2-point cushion on a 20–30 year-duration asset. - A closed quarter we haven't seen. - An unexplained record-volume gap. - The FOMC (reportedly Oct 27–28, unverified) and Q3 inside about three weeks. - A thesis that needs yields to stop rising and traffic to hold, with no edge on either.

A price that pays me for the stress case is roughly $200–210. That is up from my $190–205, and it's a judgment drawn from the table above, not a model output.

I'd turn neutral on any of these: - Q3 shows positive US comps with traffic not negative. - The 10-year closes back near or below 5.0%. - A close above $253 with RSI above 50.

Until then I'd stay out through the FOMC and the print. If you hold the bull case anyway, size it so a 12-point gap through $229 doesn't hurt. You've already said you'd need to. Bear Analyst: # Bear Closing: Fair Price, No Cushion, No Edge

This is the strongest version of the bull case so far: a small starter, hard exits, and no claim that the data settles traffic. I'll concede what's right, then show why it still doesn't justify buying before two binary events.

Conceded - Your table is two-sided in magnitude (−13% to −17% against +9% to +18%). At a 5.21% 10-year, $238 is roughly fair. I'm not calling it rich. - Your revenue, margin and EPS falsifiers are specific and fair. The stack math checks: 1.030 × 1.025 ≈ +5.6%. - The dividend is covered. Your capex table checks out, and I'm not arguing a cut. - A fixed 250.35 target is more honest than a falling 50-day. - The sentiment data is noise.

1. The buyback carries more of your return than your table admits¶

You said losing the buyback costs about 0.9 points and "leaves growth near 4%, already the base case." But the 4% base already includes the buyback. As laid out last round, 4.2% = 3.3% operating income growth + 0.9% share-count shrink, and the 1.5 points we can't explain sit on top. Your stated 4–5% range minus 0.9 is 3.1–4.1%.

Re-running your own dividend-plus-growth framework ($7.44 dividend, $238.31 price):

g = 3.1–4.1%: required return of about 6.3–7.35%, or 1.1–2.1 points over the 10-year.
g = 3.3% (operating income only): about 6.5%, or 1.3 points.

"Near 4%" holds only at the top of your range. These are outputs of an assumed framework, not forecasts.

Your capex table also shows where the buyback gives way, and it isn't at +70%. H1 capex already grew 16.8%. At +20% your table leaves $773M after dividends, against roughly $982M of non-dividend financing outflow in H1 (that figure uses your dividend estimate). Holding that pattern needs about 5–6% OCF growth. Q3 laps a record $3.43B quarter. Otherwise the buyback shrinks or the company borrows at 5%+. The dividend is safe, but the EPS growth that supports your return is not.

The "required return" is also circular, because I backed it out of the price. It equals your expected return only if g holds and the multiple doesn't compress again. A two-point cushion is thin for an asset that just lost 29% on a 118bp rise in yields. That is my judgment, since the data has no historical premium.

2. Over three weeks, your numbers put carry at about 0.4% and the swing at about 7%¶

You estimated about ±7% over the roughly 15 sessions to the FOMC and the print. Expected return is 7.25% a year, so 15 sessions of carry is about 0.4% (0.5% at g=5%). No ex-dividend date falls in the window. The cadence puts the next one near Dec 1, which is inferred. Even if ATR overstates volatility by half, the swing is about eight times the carry.

So for the next three weeks, a starter isn't a valuation bet. It's a directional bet on an FOMC meeting (reportedly Oct 27–28, unverified) and a Q3 report (date unconfirmed). You've said neither of us can answer those today.

You call waiting a "macro bet that yields spike." Cash isn't short the bond market, so the position is the bet. You're right that my triggers all arrive with higher prices. That is the cost of information, and I'd pay it.

Your falsifiers are also "don't break" tests, not "go up" tests. Q1 and Q2 both cleared the same kind of bar, and the stock still made lower lows in the following months (270.83 in May, 258.22 in August). Passing keeps you in the trade but doesn't create the rally.

3. Your exits are softest where the risk is¶

"US comps negative" is the wrong traffic bar. You conceded that price can hold revenue and margin. It can hold comps too, with CPI around 3.7% (unverified) and menu pricing doing the work. "Franchisee-profitability commentary deteriorating" isn't a threshold. The hard numbers cover revenue, margin and EPS, which are the lines price can prop up.
You contradict yourself on averaging down. The exit list says "I won't average down." The risk section calls a pullback toward 231–234 "an add zone." Both can't hold for a starter bought at 238. The add zone is only 2–5 points above your 229.20 stop, so your largest position would sit on the invalidation level. The Sept 23 gap was 12 points in one session.

4. The duration argument cuts both ways¶

You prefer the observed ladder (about 18) to the Gordon figure (about 30), arguing pass-through lowers duration. Run it. From Aug 27 to Oct 5 the stock fell 11.2% while the 10-year rose about 59bp, using the mid-August yield as the base.

At a duration of 18–19, rates explain nearly all of the drop. The stock stays fully exposed to the next leg, and the 5.31% peak is 10bp away.
At a duration of 10, rates explain about 6%. The other ~5% is company-specific, about the size of the unexplained −4.8% Sept 23 gap.

Both calculations are rough and neither of us has the yield on Sept 23. Either way, "rates problem, not a traffic problem" isn't safe.

On the curve, a fall in the 10s–2s spread from +0.51% to +0.37% means the front end is repricing faster. That is hawkish, not reassuring. CPI prints of +0.07%, +0.40% and +0.65% month over month show an accelerating trend. Yields can still fall, but the usual routes are priced as unlikely: 3% for cuts and 8% for recession.

5. Risk/reward depends on hit rate¶

With 12 points of reward against an 8.5-point stop, you break even at about a 42% hit rate. If the stop fills at the gap-through level near 217 (a 21-point loss), the break-even rate is about 64%. In between sit 240, 242.56 and the 249.90 upper Bollinger band, and the target itself is under a falling 50-day.

Where this leaves us¶

I'm not saying MCD is going lower. I'm saying it is fairly priced at today's rates, with a thin cushion, an unexplained record-volume gap and two binary events ahead. Nobody in this debate has an edge on them.

If you buy a starter anyway, your plan is the responsible version. I'd drop the add zone and make the traffic exit measurable.
I'd stay out through the FOMC and the print. I'd get constructive near $200–210, or on a clean Q3 with traffic at least flat and the 10-year back near 5.0%. That isn't a bet on rising yields. It's declining to be paid 0.4% for a ±7% coin flip.

Open items: the gap-day yield, forward EPS of $13.77, and the FOMC and Q3 dates are all unverified. Every rate attribution above is approximate. Bear Analyst: # Bear Close: Attribution Defines the Risk, It Doesn't Remove It

Short answer to your question: Partly yes. If the Sept 23 check shows a yield jump of about 20bp or more, and defensive peers also fell, I would move from "stay out" to "starter." I would not start before the FOMC. The 5.31% level isn't the blocker. The blocker is that the next rate event is about two weeks away, and if rates explain the gap, that event is the whole thesis.

Conceded - The add zone is gone, and "US guest counts negative even if comps are positive" is a better exit than the one it replaces. - Your H1 table ties to the quarterly data (revenue 12,799 → 13,616, operating income 5,880 → 6,291, EPS 5.74 → 6.10). Your 4–5% growth range is reasonable, and I get the same 6.5% required return for the g=3.3%, no-buyback case. - Your $247–255 figure for a clean 5.0% 10-year is right, and I already said I'd pay that price for information. - Position size does handle the variance. A 9% gap-through at a 5% weight costs about 0.45%.

1. Attribution doesn't justify a pre-FOMC entry¶

You wrote that the thesis has two legs, and that leg two (the long end stops rising) "is what makes money, and I have no edge on it." If the gap was rates, leg two is the entire thesis.

Attribution would remove the unknown-traffic tail. It would also confirm that MCD behaves like a roughly 19–24 duration asset. That duration comes from a 4.8% move on 20–25bp, and the number depends on the gap-day yield. The 10-year sits 10bp below its peak. The FOMC is about two weeks out, with 82% odds of another hike, and the 10s–2s spread has flattened from +0.51% to +0.37%.

Identifying the risk factor doesn't mean I'm paid for it. Buying ahead of the event that tests the leg you have no edge on means taking variance for about 0.4% of carry.

If rates explain the gap and the FOMC passes with the 10-year below 5.31%, I'd take the starter, even at a higher price.

2. A yield move alone isn't sufficient¶

Both of us are guessing at the gap-day yield. I'm not going to assume the answer, and I can't pull DGS10 here either. These points set the prior and sharpen the test:

Scale: A 20bp one-day move in the 10-year is large. The macro headlines I have cover only the past week, so they say nothing about Sept 23. My recollection, unverified, is that the September FOMC was Sept 15–16, so no rate event was scheduled that day.
Volume: The gap day's 16.6M shares was roughly 3x recent daily volume (4.5–6.5M) and 4–8x late-2025 levels. A rate-driven repricing of a defensive name should usually show up in peers too.
Coincidence risk: Your ladder was fit on one six-week leg. Finding a yield rise near a stock drop is easy. Finding peers falling alongside is harder.

So the check has two parts. Does the 10-year move at least about 20bp from Sept 22 to Sept 23, and are defensive peers (YUM, staples) down noticeably that day, not flat?

Gap-day result	My read	Action
Yield ≥ ~20bp and peers down	Rates	Starter after the FOMC if the 10-year hasn't closed above 5.31%
Yield ~10–20bp, or peers flat	Mixed, with an unexplained excess	Stay out until Q3
Yield < ~10bp, or MCD alone	Company-specific	Stay out through Q3. This matches your gate

3. Two corrections to your last round¶

The buyback logic runs backwards. You said a smaller buyback "loses less accretion than the headline suggests" because the 0.9% came at higher prices. At $238, each dollar retires about 26% more shares than at $300. That makes cutting a dollar more costly in lost accretion, not less. Your point works only if buyback dollars stay constant, which is the case where capex isn't squeezing them. If they stay constant, accretion rises to roughly 1.1%, which is a fair upside case. The downside case is a cut.

Your falsifiers measure whether the thesis breaks, not whether the print satisfies the price. At 17.3x forward earnings, the price embeds EPS of $13.77, about 12% above TTM. That figure is unverified, and it may be adjusted or a next-fiscal-year number. A Q3 EPS of $3.18–$3.31 (0–4% growth) clears every threshold in your table. It could still be read as a miss against a street number built on faster growth. I don't know the Q3 consensus. The point is that Q3 is a "don't break" test for you and may be a "disappoint" test for the tape.

Your traffic exit also fires only on disclosed guest counts. If traffic goes undisclosed, the rule says "don't add" but keeps you holding. Price can mask a traffic decline, and the exit doesn't catch that.

Where we land¶

	Bear	Bull
Price at 5.21%	Fair	Fair
Edge on Q3/FOMC	None	None
Gap-day gate	Agree on the gate and the <10bp branch	Same
Sequencing	Rates explain it: starter after the FOMC. Company-specific: after Q3	Rates explain it: starter now
Cost	A higher entry (about $247–255 on a clean confirmation)	Full exposure to the FOMC with no edge

The disagreement is now narrow. We both think MCD is fairly priced, thinly cushioned, and event-exposed. You'd own a small slice through the FOMC. I'd wait for it to clear.

I'm still out today. That's not a forecast of lower prices. I'm declining to hold an unhedged rate-and-event exposure for 0.4% of carry when the gap check and the FOMC will answer most of the open question within weeks. I'd turn constructive on any of these (my judgment): - The gap check passes and the FOMC clears without the 10-year closing above 5.31%. - Q3 shows positive US comps with traffic not negative. - The 10-year moves back near 5.0%. - Price falls to roughly $200–210.

If I'm wrong, MCD rallies through 242.56 and 250 before the FOMC, and I pay 4–7% to get in. I'd accept that cost.

Open items: the gap-day yield and peer move, forward EPS of $13.77 (adjusted vs. GAAP, and its fiscal basis), the FOMC date (Oct 27–28 is a recollection), the Q3 date, and Q3 consensus. All rate attributions here are approximate. Bear Analyst: # Bear Close: The Gate Is Unrun, So Both Our Plans Say "No Order Today"

Short answer: Your plan says to run the Sept 23 check before any order. Neither of us has run it, and I can't pull DGS10 or peer prices in this format. So today both plans produce the same action: no order. What's left is one conditional branch. If rates explain the gap, you'd take half a starter before the FOMC and I'd take it after. That is a difference in risk budget, not in analysis.

Conceded - Waiting is a variance and sizing choice, not a claim that MCD is overpriced. If $238 is fair, buying after a clean event earns the same go-forward return. - The traffic exit now works. Treating comps at or below the cited menu-price increase as negative traffic, and halving the position when neither is disclosed, closes the hole I flagged. - Your buyback offset is right. A dollar retires about 26% more shares at $238 than at $300, so a cut of up to about 20% is offset. - I haven't claimed trend persistence as an edge, and I won't start now. - The spread over the 10-year stays positive in every row of your table. My claim is that 1.3–2.0 points is thin for this duration, not that it is zero.

1. Sized to survive means sized to earn almost nothing¶

At your illustrative 2.5% weight: - Carry: About 0.4% over the window is roughly 1bp of portfolio. - Gap-through: A 9% loss costs about 22bp. - Upside branch: A +4–7% move is worth about 10–18bp.

You used the ±7% three-week ceiling to argue my event discount was too wide. Apply the same number to your stop. 229.20 is 3.8% below 238.31, and your rule triggers on a close.

Method: Zero-drift random walk, daily closes, with the ceiling treated as one standard deviation.
If ATR overstates volatility by half (about 3.5%): The chance of at least one close below 229.20 in the window is about 20%.
If it doesn't overstate: About 50%.
Caveat: This is a rough approximation, not a forecast.

So the pre-FOMC half most likely ends in one of two ways. It is stopped out at a small loss (about 3.8% plus slippage, roughly 10bp at 2.5%). Or it sits near its fill having earned about 1bp. Entering after the FOMC avoids the first outcome and gives up little in the second. The upside branch is real, but it is one branch among several, and neither of us has an edge on which one arrives.

2. Three places the plan isn't mechanical yet¶

The second half conflicts with your adds rule. The rates branch buys the second half after the FOMC if the 10-year hasn't closed above 5.31%. The adds row says "None below entry." If the stock sits at 232 with a calm 10-year, the second half is an average-down, which you have disavowed twice. Either require price at or above the first fill, or call it an add-below-entry and defend it.
"Breaks decisively above 5.31%" isn't testable. You agreed that the yield stop and the price stop are one bet, so the close-below-229.20 rule already covers it. Drop the soft wording or give it a number.
The tail numbers don't reconcile. Your table has the bad branch at −13–17%, but the text offsets it against "8–11% avoided." Whichever is right, the offset needs the good branch to be roughly 1.1–4x as likely as the bad one. We both said we have no edge on rates. That makes it a variance statement, which I accept, and not evidence that holding is free.

3. The buyback table¶

"Required return" is circular. It is backed out of the price, so it is an implied return if g holds and the multiple doesn't compress. The table mainly shows that a lower price is a better entry, which we already agree on.
A small correction in your favor. By the method your other rows use, the +20% row should be about 7.4%, not 7.2%. The conclusion doesn't change.
The offset depends on price. The roughly 20% cushion assumes repurchases near $238. If the stock is at $280, the offset shrinks to about 7%, and any larger cut reduces accretion. The cushion is thickest in the world where the stock stays cheap, which is not the world a starter is paying for.
Your framework gives no credit for capex returns. That is conservative in your favor, and I'm not scoring it against you.

4. What the gate must include¶

I'd add one item to your two-part test:

The 10-year change from Sept 22 to Sept 23.
Same-day moves in YUM and staples.
Any MCD-specific item on Sept 23. That means an 8-K, a press release, or an analyst action. The headline feed has no dates, so it can't answer this.

Whoever runs the check first should post it. If it comes back at 20bp or more with peers down, we are about two weeks of timing apart.

Where we land¶

	Bear	Bull
Price at 5.21%	Fair	Fair
Today	No order (gate unrun)	No order (gate unrun)
Rates branch	Starter after the FOMC if the 10-year closes ≤ 5.31%	Half before, half after
Other branches	Wait for Q3	Wait for Q3
Main risk to the plan	Paying 4–7% more if the 10-year drifts to 5.0% first	A stop 3.8% away inside the event range, plus a gap-through

I'm not predicting a lower price. I'm declining to hold an event-exposed position that earns about 1bp of carry, with a stop the event will probably test, ahead of an FOMC and a Q3 print where I have no edge.

I turn constructive on any of these (my judgment): - The gate comes back "rates" and the FOMC clears with the 10-year not closing above 5.31%. - Q3 shows positive US comps with traffic not negative. - The 10-year moves back near 5.0%. - Price falls to roughly $200–210.

I'm wrong if MCD closes through 242.56 and 250 before the FOMC. I'd then pay 4–7% more to get in, and I accept that cost.

Open items: the gap-day yield, peer moves and any MCD-specific news; forward EPS of $13.77 (adjusted versus GAAP, and its fiscal basis); the FOMC date (Oct 27–28 is a recollection); the Q3 date and consensus; and the split of financing outflows between buybacks and debt. The stop-touch probabilities and all rate attributions are rough.

Research Manager¶

Recommendation: Hold

Rationale: This debate ended in convergence rather than a winner. By the final round both sides agreed on the facts that matter for a rating. First, at a 5.21% 10-year, MCD at $238.31 is roughly fair. The bear moved from calling it 15–20% rich ($190–205) to calling it fair, and only wants a stress-case entry near $200–210. Second, neither side has an edge on the two binary events ahead: the FOMC (reportedly Oct 27–28, unverified) and the Q3 print (date unconfirmed). Third, the dividend is covered. Fourth, both plans say no order today, because the Sept 23 gate check hasn't been run.

The bull won the business-quality argument. H1 OCF was +17.9% and FCF +18.4%. Operating margin is about 47% and flat. H1 EPS was +6.3%. Capex can rise about 70% before FCF stops covering the $7.44 dividend. At fair value, a dividend-plus-growth framework gives a required return 1.3–2.0 points over the 10-year even with a reduced or zero buyback.

The bear won on the cushion and on timing: - The bull's 40% OCF headline was a base effect, and Q3 laps a record $3.43B quarter. - Underlying EPS growth is closer to 4% once 1.5 points of unexplained below-the-line gain are removed. - The stock just lost 29% on a 118bp rise in yields, so its rate duration is roughly 19–30 years, and the 0.45 beta was the wrong comfort. - The Sept 23 gap (-4.8% on 16.6M shares, the highest volume in the 252-session sample) is still unexplained. The last filing predates it. - The 229.20 stop is only 3.8% below price, inside a roughly ±7% three-week event range. A pre-FOMC starter most likely either gets stopped out or earns about 1bp of portfolio carry.

The bull also conceded that the chart is not the thesis. The MACD cross came below zero, and OBV has recovered only about 27% of the drawdown.

Net: the bull makes a good case against selling, since the business is compounding and not overpriced. The bear makes a good case against adding now, since the cushion is thin, the dominant risk factor is rates (where nobody has an edge), and the key attribution question can be answered cheaply within weeks. That is a genuinely balanced, fair-value setup, not one I'm forcing into neutrality, so Hold.

The evidence gaps are explicit. We don't have: - the 10-year move and peer moves on Sept 23, or any MCD-specific news that day - the basis of the $13.77 forward EPS (adjusted vs. GAAP, and which fiscal year) - confirmed FOMC and Q3 dates, or the Q3 consensus - the split of financing outflows between buybacks and debt

Strategic Actions: 1) Existing holders: keep the position at no more than a standard allocation, and don't add before the FOMC or Q3. If a holding is above standard weight, trim it back to standard ahead of the events, since the risk is event-driven variance rather than overvaluation.

2) No new position today. Before any order, run the agreed gate check: the DGS10 change from Sept 22 to Sept 23, same-day moves in YUM and consumer staples, and any MCD-specific 8-K, press release or analyst action on Sept 23.

3) Conditional entry for those with no position. Cap a starter at about half a standard allocation, e.g. 2.5% if standard is 5%. Size it so a 9% gap-through (a fill near $217) costs about 0.2–0.25% of the portfolio. (a) If the gate shows the 10-year up about 20bp or more and peers down (rates branch), enter the starter only after the FOMC, and only if the 10-year has not closed above 5.31%. (b) If the gate is mixed (10–20bp, or peers flat) or points to the company (under 10bp, or MCD fell alone), wait for Q3. © Q3 must clear all of these: revenue growth of at least 2.5% YoY against $7,078M, operating margin of at least 46.0%, diluted EPS of at least $3.18, and US guest counts not negative. If traffic isn't disclosed, US comps must exceed the cited menu-price increase.

4) Adds: only at or above the first fill, and only after Q3 clears the thresholds or on a close above 242.56. Never average down. Scale toward a full standard allocation only after both Q3 and the FOMC clear.

5) Hard exits and downgrade-to-Underweight triggers for all holders: - a daily close below 229.20 - a 10-year close above 5.31% - Q3 missing any threshold in 3©, or disclosed negative traffic - capex guidance that pushes FCF coverage of the dividend toward 1.0x If traffic is undisclosed and comps are ambiguous, halve the position. The price stop overrides passing P&L numbers.

6) Upgrade-to-Overweight triggers: the gate shows rates and the FOMC clears with the 10-year at or below 5.31%; or a clean Q3 with positive US comps and non-negative traffic; or the 10-year back near 5.0%; or price falling to roughly $200–210 with the fundamentals intact.

7) Watch levels: support at 229–231; resistance at 240, 242.56, the 249.90 upper Bollinger band and 250.35 (the pre-gap close); the 50-day near 253, falling about 0.6 a session. A daily TD sell setup could complete around Oct 20. The next ex-dividend date is about Dec 1 (inferred). Verify the FOMC and Q3 dates and the forward EPS basis before acting.

III. Trading Team Plan¶

Trader¶

Action: Hold

Reasoning: The research plan calls MCD roughly fair value at 238.31 with a covered dividend, strong H1 cash flow and stable ~47% operating margins, which argues against selling. It also leaves little cushion, a stop only about 3.8% below price inside a wide event range, and the unexplained Sept 23 gap (-4.8% on 16.6M shares). Rates and the FOMC/Q3 events are binary risks where there is no edge, so adding now is not justified. The chart shows an oversold bounce inside a primary downtrend: price is below the falling 50-day (253.04) and 200-day (283.39) SMAs, MACD crossed while still below zero, and RSI is 43.7. That supports waiting for a close above 242.56 or a clean Q3 before adding. Missing evidence includes the Sept 23 cause, the forward EPS basis, and the FOMC and Q3 dates.

Entry Price: 242.56

Stop Loss: 229.2

Position Sizing: No new buy today. Existing holders keep at most a standard allocation and trim back to standard if overweight before the FOMC and Q3. Anyone with no position may later start at about half a standard allocation (e.g. 2.5% if standard is 5%), sized so a gap-through to about 217 costs roughly 0.2-0.25% of the portfolio. Only add on a close above 242.56 or after Q3 clears the plan's thresholds, and never average down.

FINAL TRANSACTION PROPOSAL: HOLD

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: Neither of you has spoken yet, so I'll take on the arguments I expect, starting with the conservative one.

The conservative case will be that 10-year yields at 5.21% crush a bond-proxy stock with a dividend yield a bit over 3%, so you should sell or trim. I think the market has already made that argument. MCD went from roughly 27x earnings in February to 19.4x now, and it fell 28.8% from its high while EPS grew 5.7% and operating margin held near 47%. The earnings yield is about 5.2% trailing and 5.8% forward. Even if you haircut forward EPS to 7% growth, which is closer to the recent run rate, it's still about 5.5%. That matches or beats the risk-free rate, and the earnings grow. The timing is also notable. The 10-year peaked at 5.31% on Oct 5, the same day MCD printed its 229.20 intraday low. Yields have eased about 10 basis points since, and the stock is up 3.2% off its closing low. That's one coincidence, but it fits the idea that the rate shock is largely priced in.

The conservative will also say every prior bounce failed, the stock sits below falling 50- and 200-day averages, and you shouldn't fight that. I agree, and the plan doesn't fight it. It isn't buying today. The conservative is the one proposing to act into a washout: RSI sat below 30 for 11 straight readings and hit 21.8, the monthly z-score is -2.00, and the weekly TD count is at +8. Selling there means you take the worst price the trend has offered. The 229–231 zone has been tested on five dated sessions without a close below 230.88, and OBV made a higher low at the same price. That's not a confirmed bottom, but it isn't a cliff either.

On the unexplained Sept 23 gap, I'd say the same thing the trader did: it's a real unknown, and the stop is the answer to unknowns. But today's close of 238.31 matches that day's post-gap close of 238.32. It's not a filled gap, but the market has absorbed the selling that came with record volume. The headlines this week are about marketing resets and store formats, not a guidance cut or a scandal, though I only have headlines.

The conservative will also point to no insider buying and a PEG of 2.49. Zero purchases across 90 records, including at the February highs, is a base rate, not a signal. The forward EPS concern is legitimate. $13.77 implies about 12% growth against 5–7% recently, and it may be on a different basis than the GAAP trailing figure. That's why the plan waits for Q3 to clear its thresholds before adding. It's an argument for staging in, not for leaving.

Now the neutral analyst, who I expect to say "hold, wait for confirmation, size small, everyone's happy." Hold is right, but waiting isn't free. The trigger at 242.56 is only 1.8% above the close, which is roughly one ATR day. If you treat confirmation as a vague feeling instead of a pre-committed rule, you'll be buying at 250 or 253 and calling it discipline. The plan's trigger is a single level, and that's good design. I'd also be honest that the arithmetic is lopsided. From 242.56, the stop at 229.2 is 5.5% away, while the 50-day at 253.04 is only about 4.3% up. The first leg doesn't pay on its own. The payoff comes if a close above 242.56 and then 250 turns into a regime change, with the 200-day at 283.39 about 17% higher. You get that asymmetry from sizing. A gap-through to about 217 at a half-size 2.5% position costs roughly 0.22% of the portfolio, so you're paying a small, known premium for exposure to a rerating.

I'd even defend the trim-to-standard rule for overweight holders. If you can't sit through a gap, you'll sell at the bottom of it. Surviving the next 8% air pocket is what lets you take the full-size swing once the trend turns.

I'm not leaning on StockTwits. Nine labeled messages from one session aren't a signal, and a crowd mocking put holders is closer to a fade warning than a green light. The 8% recession odds, 4.2% unemployment and the heavily hawkish pricing (97% no cuts, 82% another hike) matter more. When the market is positioned for bad news, a hawkish hold or a softer inflation print is where the upside surprise lives. The risks are real: oil near $103, mortgage rates near 8% squeezing MCD's core customer, and the Q3 comps and traffic that will show whether that squeeze is hitting. I haven't confirmed the FOMC date (probably Oct 27–28) or the Q3 date, so both need to go on the calendar today.

So HOLD is the aggressive call here. It doesn't sell a washout, doesn't chase a bounce into binary events, and pre-commits to adding on a close above 242.56 or a clean Q3. It stays out of the way of a trend change while keeping the cost of being wrong around a quarter of a percent.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Conservative, you say the washout argument has expired because RSI is 43.7. I only ever used the washout to argue against selling, never for buying. The monthly z-score is still -2.00 and the weekly is -1.46, so dumping the position now still means selling into stretched readings. Your TD complaint, that I can't cite it for the washout and for buying strength, doesn't land either, because the trigger is a price rule, not a TD rule. And the two outcomes don't conflict. A weekly 9 only completes if the week ending October 23 closes below 236.50, and a rally breaks the count. So if the trigger fires, the count is dead, and if it doesn't, the count completes at the lows. The plan reacts either way.

On earnings yield, I'll give you trailing parity. 12.31 over 238.31 is 5.17% against a 5.21% ten-year, and I won't call that a premium. But look at what the parity has done. Trailing EPS was already $12.31 in late August, when the stock was 258.22. That's a 4.77% earnings yield against a ten-year of about 4.72% in mid-August. These dates don't line up exactly, so it's approximate. Still, the spread was roughly zero then and is roughly zero now. The multiple has compressed about as much as yields have risen. That's better evidence for "largely priced in" than my October 5 coincidence. I'm not claiming cheap. I'm saying further damage needs yields to keep climbing, and if they run toward the BofA 5.9% level, the plan takes about a 5.5% loss on a half position and is out. That's the design working.

You also said the week's data contradicts "priced in." That week included a hot CPI, hike odds up four points, and a ten-year back above 5.2%. After the October 8 bounce, the lowest close was 235.23, well above the 230.88 closing low. That doesn't prove anything, but the stock took the worst news of the week without making a new low. On VIX, complacency is a bigger risk for names that haven't de-rated. MCD has already gone from 27x to 19x.

Neutral, you're right that "absorption" was the wrong word for 238.31 matching 238.32. It's a round trip. You're also right that sizing, not the stop, answers the gap. But nobody addressed the better evidence. At the same close, OBV is -44.5M against -52.1M on September 23, which is 7.5M better. And the second-heaviest volume in the whole sample, 11.36M shares, came on an up day off the low, against 16.6M on the gap day. That's what buyers showing up looks like, and it's why I read 229 to 231 as a base being built. It's not proof, and sixteen million shares trading for an unknown reason is a real argument for small size. That's why the plan is half size or less, and why the free first step is to read the filings and find out what happened.

On the trigger, I'll take your two consecutive closes above 242.56. It's mechanical, it answers my worry that confirmation turns into a feeling, and it only costs a day of price. The daily TD sell count could hit 9 around October 20, so the trigger might fire into short-term exhaustion. That argues for a starter, not for no entry.

What I won't take is Conservative's full checklist of 250, the 50-day, RSI above 50 and OBV above -35M before a dollar goes in. Neutral showed that RSI and OBV probably get met on the way to 243 to 245, so the real extra requirement is 250. Look at the payoff. From 242.56 with the stop at 229.2, the 200-day at 283.39 is about 41 points up against 13 down, roughly 3 to 1. From 250, it's about 33 up against 21 down, roughly 1.6 to 1. The 200-day is falling about 0.3 a day, so say it drifts to 278. That's still about 2.6 to 1 against 1.35 to 1. I already admitted the first leg to the 50-day doesn't pay. The payoff is the leg after it, and waiting for 250 buys a prettier chart for about half the reward.

On sizing, you want a third for the starter and the trader wrote half. At the stop that's roughly 0.09% versus 0.14% of the portfolio. If the fight is that small, take the version with meaningful exposure if it works. I'll give Conservative the event gate, though. A starter after two closes is fine, but no adds until the FOMC passes, and no full size until Q3 clears the plan's thresholds. The plan shouldn't scale into events where it says it has no edge.

On overweight holders, trim to standard, not below. I'll accept that standard should be set by risk, not by the word "defensive," since a 0.45 beta didn't stop a 29% drawdown. But the plan's premise is that nobody has an edge around the FOMC and Q3. Going below standard is a directional bet that the stock goes lower, made after a 28.8% drawdown at a monthly -2 sigma reading. Trimming to standard already cuts gap risk to a size you can survive. I'll also take your point that 229.20 is a marker, not a guarantee. Run the exit on a daily close below about 229 and let sizing handle the gap.

The cost of being wrong here is roughly a quarter of a percent of the portfolio. The cost of waiting for a feeling instead of a rule is buying at 253 and calling it discipline. So I hold, with a pre-committed starter, event-gated adds and sizing built for the gap.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: I'll drop what doesn't carry weight first, so the points that do stand out.

Neutral, you're right about the weekly TD count. It completes on any weekly close under 236.50, which is mid-range and says nothing about a bottom, so I'm dropping it. You're also right that my quarter-percent figure was the cost of the starter, not the exposure people already carry, and the gap-loss budget is the right test for that. And 3-to-1 to the 200-day is the tail case. Conservative's own parity math says 278 needs a ten-year near 4.4%, so I'll judge tranches against 253 and the mid-250s.

Conservative, "base being built" overstated the OBV evidence. Two sessions account for most of the improvement, so what I can defend is a contested range where demand is showing up. You're also right that 217 isn't a floor. A repeat of the last 59-basis-point leg puts the rate model near 209. Stress it there: a third-of-standard starter bought at 242.56 loses about 0.23% of the portfolio if standard is 5%. That's the same order of magnitude as everything else we're arguing about.

Now the disagreements. Conservative, you say diligence belongs before the first dollar. I agree, and the filings check is a same-day task. But the principle applies to the first dollar sold too. Your plan trims holders to two-thirds today, before anyone has read what happened on September 23. If the cause is a block sale or index flow, you've sold a third at 238 and your own gates have you rebuying near 248. That round trip costs roughly 6 to 7 basis points at a 5% standard weight, which is your "price of information." The trim saves about 20 basis points if the stock flushes to 209. Those aren't lopsided enough to justify a flat two-thirds for everyone. Read the filings, run Neutral's gap-loss test on what the person actually holds, and trim to that if it fails.

On "the premium for confirmation is small," your 247 assumes the 50-day keeps falling 0.6 a day. That pace came from low prices replacing high ones, and over the next two weeks what rolls out is August, around 260. This is my back-of-envelope: the 50-day at 253 and the last 16 sessions near 236 imply the earlier 34 sessions averaged about 261. If the stock rallies enough to trigger anything, the average falls closer to 0.3 to 0.4 a day and sits near 249 or 250 at the FOMC. That's the 250 area you called paying up 4%.

On parity, equating a trailing earnings yield with a fixed coupon ignores that one grows. Dividend yield of 3.1 to 3.3% plus 5 to 6% growth is roughly 8 to 9% a year if the multiple merely stops compressing, against 5.2% fixed. That's an "if," and it doesn't make the stock cheap, but the risk premium isn't zero.

You're right that MCD is a rate instrument, and so is every share already held. The question isn't whether to carry rate risk, it's whether to add a small piece triggered by price rather than by a view on yields. Two closes above 242.56 are required whatever the ten-year does. And per Neutral, from that entry the stop is about 30 basis points of yield away, not 16. A two-point, six-week fit isn't a law.

Neutral, I accept your seven points with three edits. First, "if the cause can't be found, the starter doesn't happen" lets an unknowable veto forever. Time-box it. An 8-K and ratings search takes an hour, and if nothing company-specific turns up, that's the cleanest answer we'll get. I'm working from headlines only, so if something surfaces, the plan changes. Second, the tightened exit near 242 after a second tranche near 247 is about one ATR below entry. Ordinary noise hits that, and "don't re-enter until the trigger resets" then makes you chase. Give it two ATRs, near 238 to 239, which still cuts risk well below the 229 exit. Third, keep the starter before the FOMC. It only fires after price closes above the September 24 high twice, and it's sized for the gap. The adds wait for the event, and that's where the gating belongs.

I won't claim the edge here is big. The structure is what matters. The first leg alone doesn't pay, so the only way this trade works is if risk shrinks as evidence arrives. Starter on price, adds on the FOMC and Q3, and a rising exit do that, and the cost of being wrong stays at a few basis points.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Let me start with what I'm taking, because it's a lot.

Neutral, your gap-loss framing settles the trim question. Conservative, your two diligence checks are the right ones. A missing 8-K isn't a clean answer, so I'll check the ten-year on September 22 and 23 and what YUM, SBUX and the staples did those days. If MCD gapped alone and nothing turns up, the starter is a quarter of standard, not a third. I'll also log the ten-year at every fill, and I'd go further than you did. The parity math puts the 229 stop at a ten-year near 5.37%, and a ten-year close above 5.31% would show up a few points before the price stop does. So a ten-year close above 5.31% should mean no adds and a full reread, ahead of the price exit. Finally, 250 and the 50-day are your trigger for the second tranche. I agree it's the level where the pre-gap buyers get made whole.

Conservative, your trim at 209 isn't new information, it's a bigger stress. Neutral showed that the passing weight just scales with the ratio of the stresses. A gap to 209 would be about 9% overnight through the stop, nearly twice the biggest day in the sample, with VIX at 15 and no company event scheduled. If Q3 does that, the Q3 gate is what protects you. A slide there over several weeks is what the exit is for. So test the actual holding at about 217. Someone at 8% trims toward 5%, and someone at 5% passes. Your version has the 5% holder sell more than a point of portfolio at the best close in three weeks. Neutral's numbers show that's worth about 6 basis points if the stock slides to the stop and costs about 7 if it rallies to 248. That's a coin flip you'd pay for with no edge.

Now the one real disagreement left, Neutral's move of the starter behind the FOMC. I see two problems. First, the rule goes stale. If the stock is already at 248 after the meeting, "two closes above 242.56" is trivially true, and you're buying at 248 with the same 229 stop. That's 7.6% of risk, up from 5.5%, and it's the "buying at 250 and calling it discipline" problem I raised earlier, now with a rule attached. You said to size by risk, not by label, and I agree. So fix the risk instead of the share count. Budget about 9 to 10 basis points to the stop. At a fill near 243.5 that's roughly a third of standard, and at 250 it's under a quarter. The rule then stays honest at any fill price.

Second, the first leg doesn't pay if you hold the 229 stop all the way to 253. The plan doesn't do that. When price closes through 250 and the 50-day, the exit moves up to roughly 241.5, two ATRs below that fill. A starter bought near 244 then risks about 1% relative to what you paid, instead of 6%. That is about 2 basis points on a third of standard. The late-entry plan carries about 14 basis points on its first fill all the way to the same stop. The early starter is what makes the ratchet cheap. It's a small premium, a few basis points, for an option on the regime change, and the option is worth more the earlier you hold it.

I accept the event concern at a smaller size. If the trigger fires before the FOMC, take a quarter of standard, which is the same size Conservative wants when the cause is unexplained. It risks about 7 basis points to the stop. A daily sell-9 around October 20 would pull price back a few points, which doesn't reach 229. After the meeting, top up to a third only if price still holds above 242.56, inside the risk budget. The big adds stay behind the FOMC and Q3, as everyone agrees.

One more thing, since I was the one who worried about confirmation turning into a feeling. "After Q3 clears the plan's thresholds" has the same weakness, because the thresholds are never written down. I'd write them now. Last year's Q3 EPS was 3.18 on a 47.4% operating margin. A print near 3.35, which is about 5% growth, with operating margin at or above 47%, US comps and traffic not negative, and guidance not cut, is a clean pass. Comps, traffic and guidance aren't in anything I have, so someone needs to pull the numbers once the date is confirmed. Anything short of that and full size doesn't happen.

I'm still working from headlines on the news side, and the fundamentals and technicals say what they say. The business is earning 47% margins at 19x, the chart is an oversold bounce in a downtrend, and every share of MCD is a bet on the long end of the curve. The edge here is small, a few basis points either way. The plan I'd run is a risk-budgeted starter on a mechanical trigger, a ratcheting exit, event-gated adds, and sizing that survives a gap. That keeps us in position if the trend turns and costs little if it doesn't.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Conservative, Neutral, we've spent several rounds on about three basis points, so let me say what I'm giving up and then what I'd still hold.

Conservative, you're right that the ratchet argument set my best case against your worst case. Once the stop moves with the fill, a later entry carries about half the stop risk per share, and I can't call the early starter cheap by pointing at the branch where everything worked. You're also right that 12.31 over 5.31% is about 232, so the ten-year line is the price exit renamed. I'll keep it as a freeze-and-reread trigger and stop calling it an early warning. And an exit on a daily close means selling the next morning, which is one more reason sizing has to carry the gap case.

Neutral, Q3 as a veto instead of a trigger fixes what I was worried about when I wanted the thresholds written down. A print near 3.35 only moves parity from about 236 to about 240, so a pass can't carry full size and price through 250 has to earn the rest. I'll also take your point that the ten-year log should classify the fill, not veto it. A stock that has tracked the long end for six weeks will often fire its trigger because yields dipped. The protection is the freeze if they re-spike, not demanding independence from yields.

On the pre-FOMC starter, your math holds. A quarter of standard risks about 7.5 basis points to 229.2 for about 3 basis points of head start over a 250 fill. Break-even is about 71%, and a driftless walk gives about 71%. Adding 8 to 9% a year of carry and growth doesn't help, because over two weeks that's under a point of price. It's a fairly priced option, and on expected value alone I lose. So my default is now yours: no fill before the meeting.

I do want to push on "no edge", though. Everything we've said about the FOMC rests on year-level Polymarket numbers, 97% no cuts and 82% another hike by year-end. None of us has pricing for the October 27–28 meeting itself. If a hike is already mostly in the price, the event is about guidance and the surprise is a tail. If it's a coin flip, I'll wait gladly. That lookup takes minutes, and it belongs on the list next to the filings check and the September 22–23 ten-year and peer check. Right now "no edge" is partly "haven't looked."

So here is the one deviation I'd keep, written down now so it can't become a feeling. If the trigger fires before the meeting, and the September 23 check shows a shared or rate-driven move rather than MCD alone, and meeting-level pricing is lopsided, then a quarter of standard sized to the 0.2% gap budget is acceptable. Otherwise it waits. If you reject that, I won't fight over three basis points.

Conservative, you said an option's premium gets paid on the days it doesn't work. That's true of every rung of your ladder too, including the one at 250. The difference between our plans is the price of evidence, and we agree that's cheap either way.

My remaining worry is stacking. Full size now needs clean diligence, the FOMC passed, two closes over 242.56, a close over the 50-day, a Q3 pass, price holding above 250, and the ten-year under 5.31% on the day. Each gate is reasonable. Together they probably put full size at 255 to 260. Because the exit travels with the fill, risk per share stays near two ATR, so the cost is only the move we missed. I accept that. But Neutral's point that eligibility isn't obligation has a flip side. If the FOMC and Q3 land close together and the stock is already through 250, one sized fill beats three small ones in a row.

Where I land: nothing today. Do the free work: filings, ratings and analyst actions, the ten-year and peers on September 22 and 23, meeting-level hike odds, and the FOMC and Q3 dates. Holders test at about 217 against their own gap budget and trim only the excess, because selling a 47%-margin franchise at 19x on rate compression isn't a plan. New money waits for the post-FOMC trigger at a third of standard, or a quarter if the cause is unexplained, sized to the gap. Then comes the 50-day tranche with the exit raised to two ATRs below the fill. Full size needs Q3 not to veto, price above 250, and the ten-year below 5.31%. The exit stays a close below about 229 until then, and MCD counts as duration in the book.

I agree with Neutral that the outcome turns on whether existing positions survive a gap, what happened on September 23, and not mistaking a 3% bounce for a trend change. This plan covers all three.

FINAL TRANSACTION PROPOSAL: HOLD

Conservative Analyst¶

Conservative Analyst: You spent most of your turn arguing against a sell call nobody has made. I'm not asking anyone to dump MCD into a washout, and the trader isn't either. The call is hold, and we agree on that. Our disagreement is about what's inside the hold, and I think the plan carries more risk there than you admit.

Your washout argument is the foundation of your case, and it has expired. RSI was below 30 for eleven readings, but it's 43.7 now. The stock is no longer oversold. It's a bounce under falling 50- and 200-day averages, and the technical report says every earlier bounce failed (June 16, early July). Oversold also didn't protect anyone on the way down. RSI was already 26.2 on the gap day, and the stock still lost another 3% to the closing low. The weekly TD +8 cuts against you too. By the report's own reconstruction, a weekly 9 only completes if the week ending October 23 closes below 236.50, and a rally breaks the count. You can't cite that signal for the washout and also for buying strength. Those counts also include unfinished bars, so I'd hold them loosely.

On earnings yield, 5.2% trailing against a 5.21% ten-year is not "matches or beats." It's an equity risk premium of about zero, for a company with negative equity, an unexplained 4.8% gap, and debt we can't size because the tools have no breakdown. The "beats" appears only on the forward $13.77, which you concede implies 12% growth against 5–7% recently and may be on a different basis. The BofA survey puts the point where managers switch to bonds near 5.9%, about 70 basis points away. At that level even your forward yield loses. The dividend is about 3.1–3.3% against a two-year near 4.8%, so every month you wait for a rerating costs carry.

"Largely priced in" doesn't match this week's data. September CPI was +0.65% month over month, hike odds rose to 82%, and Bloomberg is running "October rate-hike bets" headlines. The ten-year is only 10 basis points off its high. The October 5 coincidence is nice, but nothing in the tools ties yields to the September 23 gap, which is the biggest move in the sample. Rates can't explain the one move we most need explained.

I'd also push back on "the market is positioned for bad news." The rates market is. Equities aren't. VIX is 15.27, in a 14–18 band for two months, with the ten-year near its highest since 2002. A hawkish hold isn't an upside surprise, and a hike with hawkish guidance lands on a market with no volatility cushion. Eight percent recession odds and 4.2% unemployment aren't a cushion for a bond proxy either. They're the reason the Fed has no reason to stop. The softer inflation print you're hoping for isn't on the calendar I can see until mid-November, after the FOMC, which I still haven't confirmed.

On the gap, 238.31 matching 238.32 is not absorption. The pre-gap close was 250.35, and the stretch from 242.56 to the 50-day at 253.04 is where everyone who bought before September 23 is underwater. You rest the all-clear on a headline feed with no article bodies, and you admitted "I only have headlines." Sixteen million shares trading for no known reason is an argument for smaller size, not for relaxing.

The trigger is where I disagree most. You call 242.56 good design because it's about one ATR from the close. A one-ATR move is ordinary daily noise, and 242.56 is just the September 24 high, so a close there only recovers a level from the day after the gap. You also granted the arithmetic. It's 13.36 points of risk to the stop against 10.48 to the 50-day, under 1:1 on the first leg, into supply. Sizing doesn't change that ratio, it only shrinks the loss each time. Your 0.22% cost is also measured from 238.31. From the 242.56 entry it's closer to 0.26% at half size, and that assumes 217 is the floor, which just repeats the last unexplained gap. At full size or overweight it's several times that.

So here's what I'd change. First, don't let a lone close above 242.56 fund an add. Use the technical report's stronger confirmation: a close through the 250 area and the 50-day, RSI above 50, OBV back above -35M. Paying up another 4% is cheaper than buying a failed bounce after at least two failed ones this summer. Second, gate the add behind the FOMC and Q3. As written, the trigger can fire the day before events you agree offer no edge, which contradicts the plan. Third, trim overweight holders below standard, not to it. Standard weight assumes a defensive stock behaving defensively. Beta is 0.45, yet the stock is down 28.8% with VIX at 15, because beta measures market sensitivity, not rate sensitivity. Your own point that "if you can't sit through a gap, you'll sell the bottom" is an argument for sizing down before the gap. Fourth, treat 229.20 as a marker, not a guarantee. It's the level everyone sees, and September 23 showed it can be skipped.

I'll concede two things. Zero insider buying is a base rate, and I won't lean on it. And I agree on StockTwits: 8 of 9 labeled posts bullish, plus put-holder taunting after one green day, is a fade warning.

I'm with you on hold. I'm not with you on pre-committing to buy at 242.56, or on carrying a standard weight into the FOMC and Q3. The data that would explain the de-rating (comps, traffic, guidance) isn't in anything we have.

FINAL TRANSACTION PROPOSAL: HOLD Conservative Analyst: Aggressive, I'll start with your earnings-yield point, because I think it works against you. You showed the earnings yield rising from about 4.77% in late August to about 5.37% at the low, while the ten-year went from about 4.72% to 5.31%. That is the stock tracking the ten-year almost one for one, and I agree with you. But follow it through. If price is roughly 12.31 divided by the ten-year, then 5.21% gives about 236, which is where we are. 5.31% gives about 232, right where the closing low printed. Your 229.20 stop corresponds to a ten-year of about 5.37%, only 16 basis points above today and six above the October 5 peak. At 5.5% parity is about 224, and at the BofA 5.9% it's about 209.

So when you say a run toward 5.9% costs the plan a 5.5% loss and then it's out, your own model disagrees. At that yield the stock is 12% below today, about nine points through your stop, and the exit happens wherever the market lets you out. A model that says this is a rate instrument also says the starter is a rate bet with a stop 16 basis points from the money, in the one variable we all agree nobody has an edge on. And parity in August wasn't support. The spread was about zero then, and the stock still lost roughly another 10%.

On "it took the worst news of the week without a new low," yields eased about ten basis points off the high over that stretch. On your parity that's worth about 2%, and the stock bounced 3.2%. That is the stock behaving like a bond, not independent strength. The three closes at 235.23, 235.65 and 235.81 are a stall. Hike odds rose four points this week while the ten-year went down, and I'd want to know which one is wrong before calling anything priced in.

On OBV, I agree it's better, and that's why I'm not selling. But by my arithmetic from the volumes in the report, two sessions, the 11.36M day on October 8 and today's 5.19M, account for about 85% of the 19.5M improvement since October 7. The bounce has recovered about 27% of the roughly 100M peak-to-trough distribution. The two heaviest days in the sample are a 4.8% drop and a 2.6% rally. That's a contested range, not obviously a base. Five tests of 229–231 in seven sessions also tend to use up bids rather than build them, though the report didn't validate that level.

The 3:1 payoff relies on a 200-day average that price hasn't been near since the failed July 7 rally. By your numbers, 41 up against 13 down breaks even only if there's roughly a one-in-four chance of getting there before the stop. Nothing in the three reports supports that after two failed rallies. After two closes above 242.56 you'd actually be entering near 244, so the first leg is about 0.6 to 1 at best, worse than the plan's own 0.78.

On sizing, you said that if the fight is that small, take the bigger version. It cuts the other way. If the upside and downside are both a few basis points, pick the version with the smaller tail.

Your TD argument shows the signal vanishes if price rises and merely "completes" if it falls. A weekly 9 only needs a close under 236.50, less than 1% below today and 3% above the lows. That doesn't tell anyone what to do.

Finally, you accepted that standard weight should be set by risk, not by the word defensive, and then declined to apply it. A trim isn't a directional bet. It's a risk budget. And it's not a sale into a washout either. The stock is at its best close since September 22, so it's about the best price the trend has offered in three weeks.

Neutral, I'll give you several things. Carry at 0.13% a month is noise, and I leaned on it too much. Negative equity is a franchise feature, so I'm dropping it as an argument. The BofA number is a flow survey, not a floor. And two consecutive closes is a real improvement over one.

But your starter numbers make my case. A third of standard from 242.56 risks about 18 basis points of portfolio on a gap to 217 and gains about 7 on the first leg to 253. That's roughly 2.5 to 1 against, before two events where we all say we have no edge. Waiting costs about 7 basis points if it runs without you. That is the price of information, and it's cheaper than the tail.

The premium for my confirmation is also smaller than you think. The 50-day is falling about 0.6 a day, so by the FOMC it's near 247, and the gap between your trigger and mine shrinks to under 2%. A breakout above the range also gets a different stop. At 242.56 you're still inside the range, so only the range low works as invalidation. Above the range, a close back below 242.56 invalidates it, so the 8.3% risk figure overstates it.

The debt detail and the September 23 cause are diligence items, and diligence belongs before the first dollar, not alongside it.

The inconsistency in your plan is that a new buyer starts at a third of standard because the evidence supports no more, while an existing holder sits at 100%. Either the starter is too small or the holder is too big.

So here's my adjustment, in terms anyone can apply. Hold, and fund nothing until the September 23 cause is read from filings and the FOMC and Q3 dates are confirmed. Use one mechanical rule, two closes above the 50-day average, which sits near 247 by the FOMC. Take a third of standard only after the FOMC passes, and go to full size only after Q3 clears the thresholds. Exit on a daily close below about 229, and rely on sizing for gaps. Existing holders go to about two-thirds of standard now and rebuild through the same gates. I'd stop at two-thirds because the plan implies a third to a half is what the evidence supports, and I don't want to be a forced seller either.

FINAL TRANSACTION PROPOSAL: HOLD Conservative Analyst: Aggressive, Neutral, let me start with what I'm giving up, because some of your points are right.

Neutral, you're right that my 2.5 to 1 set a rare tail against a base case. Stop-out versus first leg is about 9 basis points against 7, roughly 1.3 to 1 against. That's still a negative payoff, but it isn't the number I gave. You're also right that two-thirds isn't derived from anything, so I'll take your gap-loss test. But run it on the stress case Aggressive just accepted. He agreed 217 isn't a floor and that a repeat of the last 59-basis-point leg points to about 209. That's 12.3% below here, not 9%. At your 0.45% budget, the weight that passes is about 3.7%, not 5%. Run honestly, the test lands near three-quarters of a 5% standard weight, not far from where I started.

Aggressive, your sequencing point is fair: read the filings and trim the same day, in that order. But your numbers on the trim help my side. You priced the round trip at 6 to 7 basis points and the saving at about 20. So the trim pays if a flush toward 209 is even a third as likely as a rally to 248 before you rebuy. I can't prove that ratio. With hike odds at 82% and the ten-year 69 basis points from the BofA line, I wouldn't bet against it either.

On the 50-day, I'll take your arithmetic. August rolling out instead of July means it falls slower, so 249 or 250 at the FOMC is likelier than my 247. But look at what that does. The 50-day, the 250.35 pre-gap close and the 249.90 upper Bollinger band end up at the same price. That's not paying 4% for a prettier chart. It's the one level where everyone who bought before September 23 gets made whole. It's also the first thing that would show the gap was absorbed, which is what you claimed 238.31 showed earlier. A close above 242.56 only recovers the day after the gap.

On the 8 to 9% expected return, that holds only if the multiple stops compressing. Your own model says the multiple is the ten-year. You showed the earnings yield going from about 4.8% to about 5.3% as the ten-year went from 4.72% to 5.31%. If that's right, the return depends on yields not rising, the one variable none of us has an edge on. On that model, every 10 basis points is about 2% of price. Parity at today's yield is about 236, or about 240 after a good Q3 lifts trailing EPS to 12.5. So at constant yields the upside from here is roughly zero to 1%, and anything more needs yields to fall.

Neutral, you're right that the stop is 30 basis points of yield from a 242.56 entry, not 16. But the same math says reaching 242.56 with the ten-year at 5.21% means paying a 5.07% earnings yield. So the trigger can't tell real strength from the stock following a dip in the ten-year. I'd add one cheap check: record the ten-year when the trigger fires. If the stock is at 250 and the 50-day with yields unchanged, that's independent strength. If it got there because yields fell 15 basis points, it's a rate trade.

I wouldn't lean on the "front end hawkish, long end calm" reading either. It's one week of data. What usually keeps long yields calm is a growth scare, and the data offers none: recession odds are 8%, unemployment is 4.2% and September CPI was +0.65%.

On the starter before the FOMC, Aggressive says the gate belongs on adds, not on the first fill. But we all say we have no edge around the FOMC, and a starter carries the same event risk per dollar as an add. The only difference is size. The trigger is also most likely to fire in the next week, right around when the daily sell count could reach 9, around October 20. From about 244, the first leg is 9 points up against 14.8 down to the 229 exit, so about 0.6 to 1. Waiting costs a few basis points if it runs without us. Being in costs about 23 basis points in the stress case. If there's no edge, I wouldn't pay for the exposure.

On diligence, I'll accept the time-box but not the inference. "No 8-K found" isn't the cleanest answer we'll get. An analyst downgrade, a short report, a rating-agency comment or a rotation out of defensives needs no company filing. Two checks fit in the hour and can discriminate. One is the ten-year on September 22 and 23, since nothing we have ties yields to that gap. The other is what YUM, SBUX and the staples did that day. If MCD gapped alone and nothing turns up, the cause is unknown. Then the starter should be a quarter of standard, not a third.

I'll take Aggressive's two-ATR exit after the second tranche. It cuts the loss from an orderly decline. It does nothing for a gap, and that's why sizing down comes first.

So my position is this. Hold. Today, read the filings, run the rate and peer check on September 23, and confirm the FOMC and Q3 dates. Holders trim to the gap-loss test run at the 209 stress, which comes out near three-quarters of a 5% standard weight. Anything above that is risk for no edge. Buy nothing before the FOMC. After it passes, take a third of standard, or a quarter if the cause is unexplained, on two closes above the 50-day, which should be near 250. Note the ten-year when it fires. Add after Q3 clears the plan's thresholds, and run the two-ATR exit once the second tranche is on. Until then, exit on a daily close below about 229. Count MCD as duration in the book.

I'll take the cost. If it runs without us, we give up a few basis points. That's the price of information, and it's cheaper than the tail.

FINAL TRANSACTION PROPOSAL: HOLD Conservative Analyst: Neutral, you're right about the trim, and I'll drop my number. When I reran the gap-loss test at 209, I only scaled the passing weight by the ratio of the two stresses. A gap to 209 means about 9% overnight through the stop, close to twice the biggest day in the sample, and with a big enough stress you can justify any trim. So test the actual holding at about 217 against the holder's own gap budget, and trim only what fails. The budget is the real dial, and none of us knows it. The 0.45% figure was backed into from a 5% weight. A holder whose budget is 0.3% fails at 5%, and that's the test working.

You're also right that my plan was inconsistent. Buying near 250 and keeping the 229 stop is about 8% of risk on the first fill. A stop that doesn't move with the entry is a mistake, so I'm retiring that version. Aggressive, that retirement undoes your ratchet argument.

You said the early starter makes the ratchet cheap, because a fill near 244 with the exit moved up to 241.5 risks about 1%. That is the risk in the branch where price has already closed through 250 and the 50-day, which is the branch where everything worked. In every other branch the stop is still 229.2, 6.1% below a 244 fill. You set the best case of your plan against the worst case of mine, and the worst case is gone. Compared properly, a fill at 250 with the exit at 241.5 risks 3.4%, and a fill at 244 held to 229 risks 6.1% until price gets to 250. The later fill carries about half the stop risk per share, and that's the evidence-shrinks-risk idea working.

On the option, a quarter of a 5% standard at 244 risks about seven and a half basis points to 229.2. What does holding it instead of buying at 250 earn? Six points of entry price, about 2.4% on 1.25% of the portfolio, so roughly three basis points. That edge is fixed by the entry price. It's the same if the stock stops at 253 or runs to the 200-day. So you risk about seven and a half to make about three, and you need roughly a seven-in-ten chance of reaching 250 before 229 to break even. A driftless walk in that range gives about 71%. Before the FOMC, the falling 50-day or the two failed rallies, it's a wash, and a wash that carries an event we all say we have no edge on isn't worth taking. An option's premium gets paid on the days it doesn't work.

The stop is also the smaller number. That same quarter gapping to 217 loses about 14 basis points. I'm fine with risk-budgeted sizing, but write the budget on the gap, about 0.2% to 217 from the fill. That gives a third of standard at 243.5 and a quarter at 250, close to your numbers, and it's the number that matters.

I'm glad you took the ten-year line at 5.31%, but be clear about what it buys. 12.31 over 5.31% is about 232, only 2.6 points above the price exit. It's the same exit with a different name, not an early warning. Also, an exit on a daily close means selling the next morning, so the real exit sits below 229, which is another reason to size for the gap and not trust the line.

Writing the Q3 thresholds down is right, but the bar is low. EPS near 3.35, margin at 47% or better, comps and traffic not negative, and no guidance cut is roughly what the company delivered while the stock fell from 334 to 231. EPS grew 5.7% in Q2 and the stock is still down 28.8%. On the thread's own model, that print only lifts parity from about 236 to about 240 at today's yield. So the print can't carry full size by itself. Full size needs the print, price holding above 250 and the 50-day, and a ten-year below 5.31% on the day we add.

Here is where I land. Buy nothing today. Do the filings check, the ten-year and peer check for September 22 and 23, and confirm the FOMC and Q3 dates. Holders test at 217 and trim only the excess. There are no new fills before the FOMC. After it, with diligence done, two closes above 242.56 earn a third of standard, or a quarter if the cause is unexplained, sized to the gap budget with the ten-year logged. The second tranche comes on a close above the 50-day near 250, with the exit moving up to about two ATRs below that fill. A ten-year close above 5.31% freezes adds and forces a reread. Full size waits for Q3 and the conditions above. Until the second tranche, exit on a daily close below about 229. Count MCD as duration in the book.

What's left between us is a pre-FOMC fill that pays about three basis points to the winner and costs about seven and a half to the loser. If it runs without us, we give up a few basis points, which is cheap compared with taking event risk without an edge.

FINAL TRANSACTION PROPOSAL: HOLD Conservative Analyst: Neutral, I'll sign your structure: a post-FOMC trigger, a third or a quarter sized to a gap budget, a 50-day tranche with the exit moving up, Q3 as a veto rather than a trigger, and the ten-year logged at the fill so it classifies the entry and freezes adds if it re-spikes. Aggressive, I'll also give you stacking. If the stock is already through 250 when the meeting passes, one sized fill beats three small ones.

That leaves the pre-FOMC exception. You wrote it as conditions rather than a feeling, and I respect that. But you've already conceded that on expected value the pre-meeting quarter loses: it risks about 7.5 basis points to win about 3, and break-even is roughly 71% against roughly 71% for a driftless walk. The exception only makes sense if its checks turn a fair-odds bet into a favorable one, and I don't think any of the three does.

Meeting-level pricing tells you which tail you're exposed to. It doesn't tell you the price is wrong. If a hike is mostly priced, a hawkish hold is the base case and the surprise is long-end guidance. If a hold is priced, a hike is the surprise. An edge needs a view that differs from the market, and none of us has one. I'll add the lookup to the free-work list, because holders should know whether the meeting is a coin flip. But "haven't looked" and "have an edge" are different things.

I'd read the shared or rate-driven result the other way. If the September 23 gap was a rate move, MCD is trading as a pure rate instrument, which makes the FOMC matter more to the position, not less. We can also make that check pass/fail using the thread's own model. 12.31 over 250.35 is a ten-year of about 4.92%, and 12.31 over 238.32 is about 5.17%. If the stock really is the earnings yield tracking the ten-year, the ten-year should have jumped about 25 basis points between September 22 and 23. That's a big day. If it moved a few basis points, the model explains little of the largest move in the sample, there's an unidentified risk, and the starter is a quarter at most, as we agreed. If it moved 25, the gap was a rate gap and my previous point applies. Neither branch argues for a fill before the meeting.

The timing is also poor. Two closes above 242.56 could come as early as Friday, which is right where the daily sell count could reach 9 around October 20, with the meeting still a week out. You'd be buying a first leg that pays under 1:1 at the point of likely short-term exhaustion. The trader's own reasoning says adding isn't justified ahead of binary events with no edge. The exception would contradict that premise.

I'd add one consistency point. If Q3 lands within a few sessions after the meeting, a starter on for the print carries the same exposure we're avoiding before the FOMC. The gap budget is meant to absorb that, so I won't make it a separate rule. But once the dates are confirmed, I'd rather wait out both events if they're that close, since the print is what should explain the de-rating.

The gap budget also needs to cover the whole duration cluster. We all said to count MCD as duration, but nobody made that operational. If the book holds utilities, REITs, long staples or long bonds, a long-end spike hits them together. Run the 217 test on that cluster, not on MCD alone. For anyone applying the test, 217 is about 8.9% below the close, so a 0.45% budget supports roughly a 5% weight and a 0.3% budget roughly 3.4%. Set the budget before looking at the position, and trim only the excess.

So I'm with you on hold. Buy nothing today. Do the free work: filings, ratings and analyst actions, the September 22 and 23 ten-year test, peers on those days, meeting-level hike odds, and the FOMC and Q3 dates. Holders trim only what fails the cluster test at 217. There are no new fills before the FOMC. After it, with diligence clean, two closes above 242.56 earn a third of standard, or a quarter if the cause is unexplained, sized to the gap budget with the ten-year logged. The 50-day tranche comes near 250 and raises the exit to about two ATRs below the fill. A ten-year close above 5.31% freezes adds and forces a reread. Full size needs Q3 not to veto, price holding above 250, and the ten-year below 5.31%. Until the second tranche, the exit is a daily close below about 229, and sizing carries the gap case.

FINAL TRANSACTION PROPOSAL: HOLD

Neutral Analyst¶

Neutral Analyst: Both of you land on hold, and I agree. Nobody should sell a stock 3% off a washout low that still earns 47% operating margins, and nobody should build a full position under falling 50- and 200-day averages ahead of an FOMC meeting and a Q3 print whose dates we haven't confirmed. The real argument is about what goes inside the hold.

Aggressive, take your earnings yield claim first. 12.31 over 238.31 is 5.2% against a 10-year at 5.21%. That's parity, not a premium. You only get to "beats" with the forward 13.77, which you concede implies 12% growth against a recent 5 to 7%. Even your haircut version gives about 5.5%, a thin cushion over a yield near its highest since 2002. "Not expensive" isn't the same as "priced in." The October 5 timing and 238.31 matching 238.32 are the same kind of evidence, two numbers lining up. The post-gap close came right after a drop from 250 on 16.6 million shares. Getting back to the same close three weeks later, after a lower low, is a round trip, not absorption. Also, "the stop is the answer to unknowns" fails on the unknown you care about. A stop at 229.20 doesn't protect you from a gap, and sizing does. You made that point later, and it's the better argument.

Conservative, you're right about the gap, the "or" in the plan, and the need to gate adds behind events. But you overreach in places. Negative equity is a feature of a franchise model that has funded buybacks for years, and it has improved from about minus 5.2 billion to minus 1.0 billion. The fundamentals report calls the coming flip to positive mostly cosmetic, so it shouldn't shrink the risk premium. The missing debt detail is a diligence item, not evidence of a problem. The BofA 5.9% figure is the yield at which managers say they'd rotate into bonds. It's a flow survey, not a valuation floor, and MCD has already lost 28.8% on the way here. Carry is also smaller than you imply. A 3.1 to 3.3% dividend against a roughly 4.8% two-year costs about 1.5 points a year, or 0.13% a month, which is noise next to a 4.24 ATR. So carry isn't a reason to rush or to wait. And the "washout has expired" point mostly answers a trim nobody proposed. RSI at 43.7 means the daily bounce happened, but the monthly z-score of -2.00 and the weekly -1.46 are still stretched.

The trigger is where each of you is half right. 242.56 is the September 24 high, so it isn't the regime change Aggressive implies. But it isn't nothing either. It would be the first close above every close since September 22, the first higher high since the gap. That earns a starter, not a full add. A lone close is also what failed bounces produce, as on June 16 and July 7, and the daily TD sell count could reach 9 around October 20. So make confirmation mechanical, which answers Aggressive's worry about it becoming a feeling: two consecutive closes above 242.56.

On Conservative's longer checklist, OBV needs about 9 million shares of net up-volume to get back to -35M, which is roughly two ordinary up days. My rough guess is that RSI near 50 arrives in the same neighborhood. So those conditions will probably be met on the way to 243 to 245, and the real extra requirement is 250 and the 50-day. That average is falling about 0.6 a day, so it comes toward price on its own. Paying up isn't free either. Entering at 250 with the stop still at 229.2 is 8.3% of risk instead of 5.5%, so keeping the same loss budget means cutting size by a third.

Notice how small this fight is at half size. Getting stopped out from 242.56 costs about 0.14% of the portfolio, and missing a run to 253 costs about 0.11%. The money is in existing positions and in the events.

So here is my adjustment. I don't know anyone's holdings, so I'll state it in terms you can apply. If you're above standard weight, trim to standard. A gap to 217 costs about 0.45% at a 5% weight and over 0.7% at 8%. I wouldn't go below standard, because that sells into a stock that has de-rated from 27x to 19x just to dodge a risk the stop and sizing already contain. But Conservative has a fair point on label versus behavior. Beta of 0.45 didn't prevent a 29% drawdown, so set the standard by risk, not by the word "defensive."

For new money, buy nothing today. After two closes above 242.56, take a starter of about a third of standard, roughly 1.7% if standard is 5%. A gap to 217 from there costs about 0.18%. Go to half only after the FOMC passes with price still holding the range. Go to full size only after Q3 clears the plan's thresholds and price closes through 250 and the 50-day. That gives Aggressive a pre-committed rule and Conservative event gating. I'd also run the exit on a daily close below about 229, since the 2×ATR level and the recent lows cluster at the level everyone sees, and rely on sizing for the gap case.

The most valuable step costs nothing. Someone needs to find out what happened on September 23 and confirm the FOMC and Q3 dates. No tool I have can say, but a filings page and an events calendar can. If it was guidance, litigation or a credit action, the hold needs rethinking. If it was a block sale or index flow, this is a different stock than the one Conservative fears. StockTwits shouldn't move anyone, and a crowd taunting put holders after one green day argues against chasing the first leg.

Aggressive's plan asks too much of thin evidence, and Conservative's asks too much confirmation after the cheap part has gone. Tranches with a mechanical trigger keep the cost of being wrong near a quarter of a percent while leaving room if the trend turns.

FINAL TRANSACTION PROPOSAL: HOLD Neutral Analyst: Both of you now agree on hold, a mechanical trigger, event-gated adds, and an exit near 229. What's left is small in portfolio terms, so I'll say where each of you is still stretching and then pull it together.

Aggressive, three points. First, the TD argument. You said that if the trigger doesn't fire, the weekly count completes at the lows. It completes on any weekly close under 236.50, which is less than 1% below today and well above the 229 to 231 area. It would finish mid-range and say nothing about a bottom, so drop it. Second, the quarter of a percent. That's the cost of the starter. Most of the risk sits in positions people already hold. A gap to 217 is about 9% from here, which costs 0.45% of the portfolio at a 5% weight and over 0.7% at 8%. Third, the 3 to 1 to the 200-day. That target is a 17% rally to a level the stock hasn't been near since July. It's real upside, but it's a long shot, so judge each tranche against targets the stock can plausibly reach and let the risk shrink as it works.

Conservative, you're stretching in three places too. Your 2.5 to 1 against compares an 18 basis point gap loss with a 7 basis point first-leg gain. That sets a rare tail against the base case. Compared properly, the stop-out costs about 9 basis points against 7 for the first leg, roughly 1.3 to 1 against. That's still unattractive, and everyone agrees the first leg doesn't pay, but it isn't 2.5 to 1.

Your consistency argument also proves too much. Today's new-money weight is zero in your plan and mine, so "holders shouldn't carry more than a new buyer would" implies selling everything. You don't want that, so two-thirds is a compromise, not something the logic derives. Size the holding by a gap-loss budget instead. If an 8 to 9% air pocket costs more than roughly 0.45% of the portfolio, the standard weight was too big for this stock before today, and trimming fixes that. If it passes, trimming below it is a timing call.

Your earnings-yield model is useful, but it comes from a six-week, two-point fit. The same math says that if the ten-year slips to about 5.07%, parity is about 243, which is the trigger. So entering at 242.56 is already a bet that yields ease about 15 basis points. From that entry, the 5.37% yield that matches the stop is about 30 basis points away, not 16. The model also isn't static. A Q3 EPS near 3.35 against last year's 3.18 lifts trailing EPS to about 12.5 and parity to about 240 at today's yield. The risk is real, though, because the last leg up in yields was 59 basis points, and a repeat gets you to the 5.9% BofA level. That is why sizing for the gap matters more than the stop.

Your "which is wrong, hike odds or the ten-year" question has an answer in the data. The 10s-2s spread went from +0.51 to +0.37 in a week, so the front end repriced hawkish while the long end eased. Those can coexist. For MCD the long end matters most, and a hawkish hold with calm long yields isn't the bad case. A long-end spike is the bad case, and nobody has an edge on that.

Here is where I land.

Today, buy nothing. Read the September 23 filings, check debt and refinancing in the latest 10-Q, and confirm the FOMC and Q3 dates. I'm accepting your point and making this a hard gate. It costs nothing, because the earliest two-close trigger is two sessions away. If the cause is guidance, litigation or a credit action, rethink the hold. If the cause can't be found, the starter doesn't happen.
Existing holders keep the standard weight if it passes the gap-loss test, and trim to the test if it doesn't. Don't trim below it for timing.
For the starter, take about a third of standard after two consecutive closes above 242.56, with diligence clean. No adds before the FOMC.
For the second tranche, take half of standard after the FOMC passes and price closes above the 50-day, which should be near 247 by then. Once that tranche is on, move the whole position's exit up to a close back below the old range top, roughly 242, since at that point the range has been broken and that's the invalidation. Risk shrinks as the position grows.
Full size comes only after Q3 clears the plan's thresholds and price closes through 250.
Until then, exit on a daily close below about 229 and rely on sizing for gaps. Don't re-enter until the trigger resets.
Treat MCD as a rate position. If the book is already long duration elsewhere, count it that way.

This gives Aggressive a rule and a first fill, and it gives Conservative information before capital and risk that shrinks as evidence arrives. I expect it to cost us a few basis points in either direction.

FINAL TRANSACTION PROPOSAL: HOLD Neutral Analyst: We've converged more than the tone suggests. All three of us say hold, buy nothing today, find out what happened on September 23 before committing a dollar, exit on a daily close below about 229, size for the gap rather than trust the stop, and keep the big adds behind the FOMC and Q3. I'll also take Aggressive's two-ATR exit once a second tranche is on, since my 242 was only about one ATR below the fill. What's left is a handful of disputes where each of you is right on one point and stretching on another.

Conservative, take the trim first. You re-ran the gap-loss test at 209 and got 3.7%. But the 0.45% budget came from a 9% gap on a 5% weight, so re-running it at a harsher stress just shrinks the weight by the ratio of the two stresses. Pick a big enough stress and you can justify any trim. Also, 209 isn't a gap. It's where the rate model lands if the ten-year drifts toward 5.9% over weeks, which is the orderly decline the exit exists for. Reaching 209 as a gap means about 9% overnight through a 229 stop, nearly twice September 23. That gap applied from 229.2 lands near 218, which is what my 217 was.

The trade-off numbers you said favored you also shrink on inspection. Trimming a third of a 5% position saves about 20 basis points only if the stop fails all the way to 209. If the stock slides to 229 and you exit, the trim saves about 6 basis points, and the round trip if it rallies to 248 costs about 7. In the base case the trim is a coin flip, and it only pays in the tail. That's a job for a gap-loss budget, not a timing trim. So test the actual holding at about 217, trim only what fails, and don't go below standard. Someone at 8% trims toward 5%. Someone at 5% passes.

Your entry plan also has an inconsistency. You'd buy a third of standard on two closes above the 50-day, near 250, but keep the exit at 229 until the second tranche. That's about 8.4% of risk, roughly 14 basis points, versus the 9 you objected to at 242.56. Earlier you said a breakout above the range deserves a different stop, and you were right. Size by risk, not by label. I'd keep 250 and the 50-day as the second-tranche trigger. The pre-gap close, the upper band and the average all cluster there, and a stop can legitimately move up. As the first trigger it demands the most confirmation and risks the most per share.

Aggressive, you win on the trigger and lose on timing. Two closes above 242.56 is a good rule and the first real evidence that price is digesting the gap. But you conceded the first leg doesn't pay, and Conservative is right that a starter carries the same event risk per dollar as an add. A pre-FOMC starter buys about 7 points of a sub-one-to-one leg, roughly 5 basis points, in exchange for the FOMC gap. It would also likely fire around October 20, when the daily sell count could hit 9. So I'd move the starter behind the FOMC but keep your trigger: after the meeting, two closes above 242.56 with diligence done.

You also two keep treating a price trigger as neutral on rates. If price tracks 12.31 over the ten-year, 242.56 corresponds to a yield near 5.07%, so the trigger mostly fires when yields dip. Conservative's cheap fix is right: write down the ten-year at each fill, and treat a close above 5.31% as a stop-and-reread line alongside the price exit.

On diligence, the time-box is right, since an unknowable shouldn't be a permanent veto. But Conservative is right that a missing 8-K isn't a clean answer. Check the ten-year and YUM, SBUX and the staples on September 22 and 23, plus any analyst or ratings action. If the move was shared or rate-driven, it's benign. If MCD gapped alone and nothing turns up, the starter shrinks to a quarter rather than disappearing.

On valuation, I think you're arguing past each other. If price follows EPS over the ten-year, then at constant yields the return is EPS growth plus dividend, roughly 8 to 9% a year, which is Aggressive's number. Conservative's "zero to 1%" counts only one quarter's EPS bump. But each 10 basis points costs about 2% of price, so that return covers only about 40 to 45 basis points of yield rise over a year, and the last leg was 59 in six weeks. So the premium isn't zero, but it's thin. That argues for small size and patience, not for rushing or leaving.

So here is the plan. Today, buy nothing. Read the filings, run the rate and peer check, and confirm the FOMC and Q3 dates. Existing holders keep standard weight if the gap-loss test at about 217 passes at their own budget, and trim only the excess. After the FOMC passes, with diligence clean, two closes above 242.56 earn a third of standard, or a quarter if the cause is unexplained. That's about 1.7% if standard is 5%, risking roughly 9 basis points to the stop. Two closes above the 50-day, near 249 or 250, bring it to half of standard, and the exit then moves up to about two ATRs below that fill. Full size waits for Q3 to clear the plan's thresholds with price holding above 250. Until the second tranche, the exit is a daily close below about 229. Count MCD as duration in the book.

The money in this argument is small, a few basis points either way. What matters more is the diligence, whether existing positions survive a gap, and recognizing that every share of MCD is a bet on the long end of the curve.

FINAL TRANSACTION PROPOSAL: HOLD Neutral Analyst: We've narrowed this to one live disagreement and a few refinements, so I'll take those in turn and then give the plan I'd hand the trader.

Aggressive, you're right about the stale trigger. If the stock is already at 248 after the FOMC, "two closes above 242.56" is trivially true, and a fixed share count turns into the "buy at 250 and call it discipline" problem you warned about. Sizing each fill to a gap budget fixes that, and Conservative has accepted it too. But two of your arguments for filling before the meeting don't hold up.

First, the ratchet only makes the position cheap in the branch where price has already closed through 250 and the 50-day. That's the branch where the second tranche is justified anyway. In every other branch the starter sits about 6% above a 229 exit.

Second, the option framing doesn't help you. Conservative's numbers say you pay about 7.5 basis points for about 3. Break-even is roughly 71% odds of reaching 250 before 229, and a driftless walk from 244 gives about 71%. That's a fairly priced option, and fairly priced isn't cheap. Nobody here claims an edge going into an FOMC. I'd also say the 5.31% ten-year line is mostly the price exit renamed, since 12.31 over 5.31% is about 232. Keep it as a freeze on adds and a prompt to reread, but don't count it as extra protection.

Conservative, your math is right, but I'd push on how much weight you put on it. A wash is a wash. The starter's expected cost before the meeting is near zero and its variance is a few basis points, against roughly 45 basis points of gap exposure on a standard holder at a 5% weight. If the FOMC worries you, that's where the worry belongs, and your holder test at 217 is the right place for it. I'm skipping a pre-FOMC fill because it's priced at fair odds, adds an event, and gains nothing from going early. I'm not skipping it because it's dangerous.

On the ten-year log, I like it, but it should classify and not veto. All three of us call MCD a rate instrument, and parity puts 242.56 at a yield near 5.07%. A trigger that fires because yields eased is still valid as long as the thing we fear, a yield re-spike, is handled. That's what the freeze does. Demanding strength independent of yields from a stock that has tracked them for six weeks asks it to behave like something it isn't.

On Q3, I agree the bar Aggressive wrote is low, and a clean print mostly moves parity from about 236 to 240. So treat Q3 as a veto, not a trigger. A miss on comps, traffic or guidance blocks full size and should force holders to reread. A pass only makes full size eligible, and price through 250 is what earns it.

On the open item, I say no fill before the FOMC. The diligence will be done in time either way, and the post-meeting trigger is the same rule with less noise.

One practical flag. The FOMC is probably October 27–28, and Q3 has historically landed in late October or early November. Neither date is confirmed. If they fall within a week of each other, the staged plan compresses, and the stages shouldn't turn into a calendar. A cleared event makes you eligible to buy, not a buyer. Each step still needs its price condition.

Here's the adjustment I'd make to the written plan. Today, buy nothing. Read the filings and any ratings or analyst actions. Check the ten-year and YUM, SBUX and the staples on September 22 and 23, and put the FOMC and Q3 dates on the calendar. If the gap was guidance, litigation or credit, rethink the hold.

Holders should test their position at about 217 against their own gap budget and trim only what fails. Don't trim below that for timing.

After the FOMC, with diligence clean, two closes above 242.56 earn a third of standard, or a quarter if the cause is still unexplained. Size it so a move to 217 costs about 0.2% of the portfolio, and log the ten-year at the fill. That replaces the plan's half-size start and its "or a clean Q3" trigger.

The second tranche takes the position to about half of standard on a close above the 50-day, near 250, checked again against the gap budget. If the stock is already there at the meeting, make it one sized fill. The exit then moves to about two ATRs below that fill.

Full size needs three things: Q3 clears the written thresholds, price holds above 250, and the ten-year is below 5.31%. A ten-year close above 5.31% freezes adds until it's back below.

Until the second tranche, the exit is a daily close below about 229. The real fill can be lower, which is why sizing comes first. After a stop-out, wait for a fresh trigger, not just a bounce. And count MCD as long duration in the book.

We've spent several rounds on a few basis points of starter size. The things that move the outcome are whether existing positions survive a gap, what happened on September 23, and not mistaking a 3% bounce inside a downtrend for a trend change. This structure covers all three and costs little if we're wrong in either direction.

FINAL TRANSACTION PROPOSAL: HOLD Neutral Analyst: We're down to one live disagreement, so I'll take that first and then give you the plan as it now stands.

Aggressive, I'll give you the meeting-level lookup. Our FOMC talk rests on year-end Polymarket numbers, and the odds for the October 27-28 meeting itself take minutes to find. Holders should have them. But I think your pre-FOMC exception is close to vacuous, and the thread's own model shows why. If MCD is 12.31 over the ten-year, the move from 250.35 to 238.32 on September 23 implies the ten-year jumped roughly 25 basis points in one session. That is very unlikely, since the whole August-to-October climb was about 59 basis points over six weeks. So the likely result of the rate check is "not a rate move," and then your condition fails and the quarter-size starter is off. If the peers gapped too, that's sector flow, and it says nothing about meeting risk. Lopsided meeting pricing tells you which tail you're exposed to, not that the price is wrong. You've already accepted that the pre-meeting quarter is a fairly priced option. A fair price isn't a reason to take an extra event, so I'd drop the exception.

Conservative, you're right on that point, and the cluster test is the most useful thing added this round. Everyone said to count MCD as duration, and running the gap test on the whole cluster of utilities, REITs, long staples and long bonds is how you make that real. Set the budget first, then look at the position.

I'd push back on "wait out both events if they're close." You said the gap budget absorbs Q3 risk, then said you'd rather wait. Both can't be the rule. If you skip every starter near an event, eligibility turns into a calendar, and you drift toward the one big fill at 255 to 260 that you and Aggressive both said is worse than a sized one. So the budget should do the work. If Q3 lands within about a week after the meeting, start at a quarter instead of a third and keep going. And Q3 stays a veto, not a trigger.

One small correction on sizing, since we've been loose with it. A fixed 0.2% gap budget to 217 supports about 1.8% of the portfolio at a 243.5 fill and about 1.5% at 250. That's roughly 37% and 30% of a 5% standard. So the share count already shrinks as the price rises, and what turns a third into a quarter is mostly the haircut for an unexplained September 23, not the fill price. The budget carries the risk control, and we can stop debating thirds versus quarters.

Here is where I land, with the usual caveat that I'm working from headlines, derived figures and a book I can't see.

Today, buy nothing. Do the free work: the filings, ratings and analyst actions around September 23, the ten-year and the peers (YUM, SBUX, staples) on September 22 and 23, meeting-level hike odds, and the FOMC and Q3 dates. If the cause was guidance, litigation or credit, rethink the hold itself.

Holders set their gap budget first, then test the whole duration cluster at about 217 and trim only the excess. Don't trim below that for timing. That would be a directional bet after a 28.8% drawdown.

There are no new fills before the FOMC. After it, with diligence done, two closes above 242.56 earn a third of standard, or a quarter if the cause is unexplained or Q3 is close behind. Size it to the 0.2% gap budget and log the ten-year at the fill. If the stock is already through 250 and the 50-day, make it one sized fill.

The second tranche takes the position to about half of standard on a close above the 50-day, probably near 249 or 250. The exit then rises to about two ATRs below that fill. A ten-year close above 5.31% freezes adds and forces a reread. Full size needs three things: Q3 doesn't veto on comps, traffic, margin or guidance, price holds above 250, and the ten-year is below 5.31% that day. Until the second tranche, the exit is a daily close below about 229, and sizing has to cover the gap case since the real fill can be lower. After a stop-out, wait for a fresh trigger, not just a bounce.

Neither extreme is right. Aggressive's plan paid for exposure at fair odds into an event nobody has an edge on, and Conservative's would have trimmed holders for timing and bought only after the cheap part of the move. This one costs a few basis points either way. What actually moves the outcome is whether existing positions survive a gap, what happened on September 23, and not mistaking a 3% bounce inside a downtrend for a trend change.

FINAL TRANSACTION PROPOSAL: HOLD

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Hold

Executive Summary: Hold MCD at $238.31. Buy nothing today: run the September 23 diligence (filings, ratings or analyst actions, the 10-year move and YUM/SBUX/staples moves on Sept 22-23) and confirm the FOMC (reportedly Oct 27-28) and Q3 dates. Existing holders set a gap-loss budget, test their whole duration cluster against a gap to about $217, and trim only the excess (e.g. a 0.45% budget supports about a 5% weight). They should not trim below that for timing. New money waits until after the FOMC; then two closes above 242.56 earn a starter sized so a gap to $217 costs about 0.2% of the portfolio (about a third of standard, or a quarter if Sept 23 is unexplained or Q3 follows within about a week), with a daily close below about 229 as the exit and a 3-6 month horizon toward $250.

Investment Thesis: DECISION: All three risk analysts and the Research Manager converged on Hold, and the evidence is genuinely balanced, not just disputed. The disagreement had narrowed to a few basis points of starter sizing, so I weighed it on the merits.

AGAINST SELLING (bull case, which wins on business quality): - Q2'26 diluted EPS was $3.32 (+5.7% YoY), revenue $7,099M (+3.7%), operating margin about 47%. - Operating cash flow ran 1.19x net income; Q2 OCF was +40% YoY, though partly a base effect. - Equity improved from -$5.2B to -$1.0B, and the $7.44 dividend (about 3.1%) is covered. - The multiple de-rated from about 27x to 19.4x trailing while earnings grew. - The monthly z-score of -2.00 and weekly of -1.46 still show stretched selling. - Selling a 47%-margin franchise at 19x after a 28.8% drawdown is a directional bet nobody has evidence for.

AGAINST ADDING (bear case, which wins on cushion and timing): - The trailing earnings yield of 12.31/238.31 = 5.17% is at parity with the 5.21% 10-year. The earnings yield has tracked the 10-year almost one-for-one: about 4.77% vs 4.72% in August and about 5.37% vs 5.31% at the low. MCD is effectively a long-duration rate instrument, and the 0.45 beta was false comfort. - Forward EPS of $13.77 implies about 12% growth against a recent 5-7%, and its basis is unknown. - The Sept 23 gap (-4.8% on 16.6M shares, the record volume in the sample) is unexplained. - Price is below a falling 50-day (253.04) and 200-day (283.39). MACD (-4.97) is above its signal but below zero, and RSI is 43.7. OBV has recovered only about 27% of the distribution. - The 229.20 stop is only 3.8% below price, inside the event range. - There were zero insider purchases across 90 records.

ADJUDICATING THE RESIDUAL DISPUTES: 1) I reject Aggressive's pre-FOMC starter. A quarter of standard risks about 7.5bp to 229.2 to gain about 3bp of head start over a fill near 250. Breakeven needs about a 71% chance of reaching 250 first, and a driftless walk gives about 71%. That is a fairly priced option into an event where nobody has an edge. A daily TD sell-9 could also land around Oct 20. 2) I reject Conservative's flat trim to two-thirds. Re-running the gap test at a harsher $209 stress just scales the answer by the stress ratio. In the base case the trim is a coin flip: it saves about 6bp on a slide to the stop and costs about 7bp on a rally to 248. 3) I adopt Neutral's structure.

THE PLAN: - Holders: set a gap-loss budget first and test the whole duration cluster (utilities, REITs, long staples, bonds) at $217, which is 8.9% below the close. Trim only what fails. - Starter: after the FOMC, with diligence clean, two closes above 242.56. Size it to a 0.2% gap budget to $217, which is about 1.8% of the portfolio at a 243.5 fill and about 1.5% at 250. Log the 10-year at each fill. - Second tranche: up to about half of standard on two closes above the 50-day (near 249-250 by the FOMC). Then raise the exit to about 2 ATR (about 8.5 points) below that fill. - Full size requires three things: Q3 does not veto, price holds above 250, and the 10-year is below 5.31%. - Until the second tranche, exit on a daily close below about 229, and rely on sizing for gaps.

WHAT CHANGES THE RATING: Downgrade to Underweight if any of these happen: - the Sept 23 cause is company-specific (guidance, litigation, credit) - a daily close below 229.20 - Q3 misses any veto threshold: revenue growth below 2.5% vs $7,078M, operating margin below 46.0%, diluted EPS below $3.18, or negative US traffic (or, if traffic is undisclosed, comps not exceeding menu pricing) - capex guidance that pushes FCF coverage of the dividend toward 1.0x A 10-year close above 5.31% freezes adds and forces a reread. On parity that level is about $232, essentially the price exit. Upgrade to Overweight on a clean Q3 plus two closes above the 50-day near 250 with the 10-year at or below 5.31%, or on a fall to $200-210 with fundamentals intact.

PRICE TARGET (method 1, valuation on the earnings-yield parity the stock has tracked): - Next-12-month EPS = 12.31 x 1.06 (midpoint of the 5-7% run rate, not the unverified 12% implied by $13.77) = 13.05. - 13.05 / 0.0521 (current 10-year) = about $250. - Cross-check: the technical cluster of the 249.90 upper Bollinger band, the 250.35 pre-gap close, and a 50-day projected near 249-250. - Sensitivity: each 10bp in the 10-year moves the price about 2%. At 5.31% the value is about $246, at 5.5% about $237, at 5.9% about $221. - Implied return is about 4.9% in price plus about 1.6% in dividend over 3-6 months. Against a stop 3.8% away and a $209-217 gap tail, that is consistent with Hold, not Overweight.

DATA GAPS (these lower confidence): - the cause of the Sept 23 gap - the basis of the $13.77 forward EPS - confirmed FOMC and Q3 dates, meeting-level hike odds, and the Q3 consensus - the debt and buyback breakdown

Current Price: 238.31

Price Target: 250.0

Confidence: Medium

Time Horizon: 3-6 months